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Abstract
Extended mechanical stimulation of articular cartilage in an in vitro model explant
system promotes growth and repair. An alternating day mechanical loading protocol
consisting of dynamic sinusoidal compression results in long term extracelluar matrix
macromolecule biosynthesis and increased biosynthetic rates in the cartilage system. The
protocol uses total glycosaminoglycan and DNA content assays to measure matrix
macromolecule biosynthesis and uses L-3H-proline and 3 5S-sulfate radiolabel
incorporation rates to measure rates of biosynthesis. The results also demonstrate the
feasibility of replacing the fetal bovine serum and L-ascorbic acid components of the
typical explant feeding medium with ITS (insulin-transferrin-selenium solution) and
acorbyl-2-phosphate in anticipation of future long term studies of the synergistic
pathways of dynamic compression and IGF-I stimulation for cartilage growth and repair.
Thesis Supervisor: Alan J. Grodzinsky
Title: Professor of Electrical, Mechanical, and Biological Engineering
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Chapter 1 - Introduction
1.1 Background
Articular cartilage is a dense connective tissue that lines the end of synovial or
bag-like joints. Cartilage is responsible for the mobility of joints, including the properties
of dissipating stresses or shocks and lowering frictional forces within joints. It is
comprised of chondrocytes fixed in an extracellular matrix (ECM) consisting of collagen
type II, aggrecan, and other highly charged proteoglycans (Figure 1.1). Cartilage
proteoglycans are proteins that contain covalently linked glycosaminoglycan chains
(chondroitin sulfate and keratin sulfate) attached to a polypeptide backbone known as the
core protein [1] and the core proteins are noncovalently bound to a long filament of
hyaluronate.
Aggrecan Hyaluronate
Collagen II Chondrocyte By Nora Szaz
Figure 1.1. Cartilage physiology.
Cartilage is a poroelastic tissue in which proteoglycans contain fixed negative
charges that contribute to the overall net negative charge density of the tissue.
Compression of cartilage causes deformation of the chondrocytes and the extracellular
matrix, which lead to repulsive forces between the negatively charged proteoglycans.
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These forces result in fluid flows in the tissue, which induce streaming potentials and
currents. The repulsive forces between the proteoglycans also contribute to the stiffness
of the cartilage. Thus, cartilage is a complex system in which chondrocytes respond to
loading or other physical stimuli by changing rates of biosynthesis of extracellular matrix
biomolecules. These changes in the extracellular matrix can, in turn, cause changes in
mechanical properties of the tissue, contributing to an overall metabolic feedback system.
Osteoarthritis, a degenerative joint disease, is a common defect of articular
cartilage and underlying bone. Symptoms of osteoarthritis include the breakdown of the
cartilage in the joint, which leads to pain and a loss of movement as the opposing bones
rub against each other. Osteoarthritis results from a combination of risk factors including
age, genetics, obesity, and traumatic joint injuries due to sports, accidents, and work-
related activities. Articular cartilage defects may require novel regenerative and repair
strategies to restore biological and functional activity to the damaged cartilage tissue.
It is generally accepted that physical stimuli in the environment of the tissue can
cause significant changes to the synthesis and degradation of matrix macromolecules;
however, the cellular mechanisms that influence the response of the chondrocyte to those
stimuli are still not well known. Biochemical studies have also shown that growth factors
and cytokines also regulate many of the same responses. Thus, recent studies have
indicated that there are multiple pathways by which cartilage can sense and respond to
physical stimuli [2]. Because these pathways are difficult to study in vivo, in vitro
models such as cartilage explant and chondrocyte/gel systems have been used to
investigate these mechanisms.
6
Insulin-like growth factor-I (IGF-I) is a 7.6 kDa polypeptide synthesized by
cartilage via the chondrocytes, as well as by the liver. IGF-I binds to cell surface
receptors in the chondrocyte and increases synthesis of extracellular matrix components
such as collagens and proteogylcans [3, 4]. Also, IGF-I has been shown to inhibit or
counteract catabolic processes or pathways which usually result in cartilage tissue
breakdown [5, 6]. Furthermore, Sah et al. have demonstrated that long term treatment of
articular cartilage explants with IGF-I have demonstrated increased biosynthetic rates,
altered extracellular matrix composition, and improved biomechanical tissue properties
[7]. IGF-I levels in joint synovial fluid have also been shown to be elevated in
osteoarthritis and rheumatoid arthritis, suggesting a reparative motivation for the
presence of IGF-I [8].
Bonnassar et al. have demonstrated the effect of short term dynamic compression
and IGF-I on articular cartilage explants [9]. The study showed that IGF-I increased
protein synthesis by 90% and proteoglycan synthesis by 120% in bovine patellofemoral
cartilage and that short term, low-amplitude, sinusoidal dynamic compression increased
protein synthesis by 40% and proteoglycan synthesis by 90%. They also showed that
simultaneous dynamic compression and stimulation by IGF-I resulted in increased
protein and proteoglycan synthesis by 180% and 290%, respectively. Furthermore, their
studies indicated that dynamic compression accelerated the response of the cartilage of
IGF-I and increased the amount of IGF-I transported into the extracellular matrix.
However, the two different stimuli appeared to act through distinct cellular mechanisms,
as suggested by the contrasting kinetics of the two responses.
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Using a three-dimensional self-assembling peptide hydrogel system, Kisiday et al.
investigated the possibility of using the peptide hydrogel as a scaffold for chondrocyte
seeding, resulting in the synthesis of a cartilage-like extracellular matrix in culture [10].
In their study, they investigated the effects of long-term dynamic compression on
biosynthetic rates of chondrocyte seeded within the peptide gel, specifically through
loading protocols involving a combination of periods of loading and free-swelling
culture. They found that an alternate day loading protocol resulted in increased total
proteoglycan and protein synthesis in the system.
Previous studies have shown the effect of injurious (high-amplitude) compression
on cartilage explants [11, 12]. Injurious mechanical compression typically led to
decreased biosynthetic rates, tissue swelling, and chondrocyte apoptosis. This type of
injury is representative of the type of traumatic injury believe to be a risk factor for
development of osteoarthritis. Cosman et al. showed the effect of IGF-I on the repair of
injured cartilage explants [13]. Following injurious compression, they demonstrated that
cartilage exposed to IGF-I stimulation showed higher biosynthesis rates than non-treated
samples.
Ascorbic acid is an antioxidant and vital to cartilage metabolism. L-ascorbic acid
is typically used as a component in the feeding medium for chondrocyte and cartilage
explant model systems. However, the aqueous half-life of L-ascorbic acid is known to be
approximately two days in medium. A2P, an ascorbyl-2-phosphate magnesium salt
derivative, is an alternative source of ascorbate that is a potent antioxidant with a longer
half-life than L-ascorbic acid and is internalized, desphophorylated, and concentrated in
the aqueous phase of the chondrocyte. Previous studies have shown that A2P can be used
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in place of L-ascorbic acid in the feeding medium for guinea pig cartilage in long term
metabolism studies [14].
Thus, the previous studies indicate that the synergistic use of long term, dynamic
compression and recombinant growth factors has the potential to stimulate long term
growth and repair in articular cartilage. The ability to stimulate long term growth and
repair in cartilage would be an important step in treating and understanding common
articular defects such as traumatic injury or osteoarthritis.
1.2 Objectives and hypotheses
The major goal of this Master of Engineering thesis research project was to
develop an experimental protocol to demonstrate long term cartilage growth and repair in
articular cartilage explants. The protocol has used a low-amplitude, alternative day
sinusoidal dynamic compression loading procedure as the major physical stimulator of
growth and repair. The hypothesis was that the protocol would result in elevated levels
of extracellular matrix protein biosynthesis rates and total matrix protein content.
In preparation for future work involving synergistic stimulation of cartilage
growth and repair by the long term loading protocol and by IGF-I stimulation, another
goal was to isolate and observe the effects of IGF-I under both long term free swelling
and mechanical loading conditions by replacing fetal bovine serum (FBS), a nutrient rich
supplement of the typical explant feeding medium containing numerous growth factors
with ITS (an insulin-transferrin-selenium nutrient solution). Furthermore, the possibility
of replacing L-ascorbic acid in the feeding medium with a more stable form, A2P was
also investigated. The hypothesis was that the replacement of the FBS and L-ascorbic
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acid components would have no adverse effects on the long term cartilage growth and
would set the stage for future IGF-I studies.
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Chapter 2 - Methods
2.1 Materials
Knee joints from freshly slaughtered 1-2 week calves were from Research 87
(Marlborough, MA). High glucose Dulbecco's modified Eagle's medium (DMEM),
HEPES buffer solution, phosphate-buffered saline (PBS), and sodium pyruvate were
from GIBCO (Grand Island, NY). Fetal bovine serum was from HyClone (Logan, Utah).
PenStrep, L-ascorbic acid, proline, non-essential amino acid solution, and ITS were from
Sigma-Aldrich (St. Louis, MO). Proteinase K was from Roche Diagnostics
(Indianapolis, IN). Sodium sulfate was from Mallinckrodt Specialty Chemicals (Paris,
KY). L-[ 3H]-proline was from Amersham Biosciences (United Kingdom). Sodium
[35S]-sulfate was from Perkin-Elmer (Boston, MA). Ecolume scintillation fluid was from
Fisher (Boston, MA). Dimethylmethylene blue dye was from Polysciences (Warrington,
PA). Hoechst dye was from Hoechst Celanese (Short Hills, NJ).
2.2 Cartilage explant and culture
Articular cartilage plugs of 1 mm thickness and 3 mm diameter were harvested
from freshly slaughtered 1-2 week old calves as described previously [15]. In summary,
a drill press and hollow 9 mm drill bit were used to obtain cylindrical cores of cartilage
and bone from the bovine femoropatellar groove. A PBS and antibiotic solution was
used to prevent dehydration and infection. The cores were inserted into a polysulfone
sample holder (Figure 2.1) for a sledge microtome (Figure 2.2, Model 860, American
Optical, Buffalo, NY) and the uneven surfaces of the cartilage were removed. The cores
were then sliced to obtain the next two 1 mm layers of cartilage. Next, the slices were
punched with a 3 mm dermal punch (Miltex Instruments, Lake Success, NY) under
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sterile conditions to obtain the final cartilage plugs. The plugs were then placed in 0.5
mL of prepared medium and allowed to reach metabolic steady state in 48-well dishes for
48-60 hours in an incubator at 370 C in 5% CO 2 atmosphere. Figure 2.3 illustrates the
explant procedure. The culture medium for dynamic compression initially consisted of
high glucose DMEM with phenol red, 10% fetal bovine serum (FBS), 10 mM HEPES
buffer, 1 mM sodium pyruvate, 20 ug/mL ascorbate, 0.1 mM non-essential amino acids,
0.4 mM L-proline, and PenStrep (multiple antibiotics).
Figure 2.1. Cartilage core polysulfone holder.
Figure 2.2. Sledge microtome.
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Joint Core Slice Plug
9 mm 3 mm
1 mm I I r
Drill Press Microtome Dermal
Punch
Figure 2.3. Explant protocol diagram.
2.3 Mechanical loading (dynamic compression)
Cartilage plugs were placed into individual wells of a specially machined
polysulfone compression chamber (Figure 2.4) with 0.5 mL of media per well. The plugs
were held under uniaxial, radially unconfined compression between platens in the base of
the chamber and the chamber lid. The compression chamber was then placed inside a
custom-built compression apparatus (Figure 2.5) housed in a standard incubator at 370 C
in 5% CO 2 atmosphere. For the experiments, cartilage plugs matched from the same slice
were used as controls. The general dynamic compression protocol consisted of 4 cycles
of 45 minutes of dynamic stimulation per 6 hours every other day. The sinusoidal
compression had a magnitude of 3% and a frequency of 0.1 Hz. The number of
stimulation days (initially 4), the media composition, and the radiolabel concentration
and period were varied during the course of the study. During the course of the
compression protocol, the feeding medium for the cartilage plugs was replaced every two
days. Figure 2.6 shows a timeline of a typical experiment.
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Figure 2.4. 12 well, polysulfone load chamber (Delta series), lid on left and base on right.
Figure 2.5. Incubator-housed, custom built compression apparatus.
Experimental Protocol Time Course
Day
0 1 2 3 4 5 6 7 8 9 10
-Explant -DC #1 -FS -DC #2 -FS -DC #3 -FS -DC #4 -Label -Assay
-Incubate -Media -Media -Media -Media -Disest -Store
Kev-
DC = Dynamic Compression
FS =Free Swvell
24 Hour Dynamic Compression Time Course
Hour
0 0.75 6 6.75 12 12.75 18 18.75
-DC -Free Swell -DC -Free Swell -DC -Free Swell -DC -Free Swell
Figure 2.6. Sample protocol experimental timeline.
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2.4 Biochemical and biosynthetic analyses
Following the compression protocol, the cartilage plugs were radiolabeled in
preparation for the biochemical and biosynthesis assays described below. The total
radiolabel incubation time varied across the experiments to observe different time points.
The radiolabeled plugs were then digested overnight in a proteinase K solution prior to
any of the assays.
2.4.1 Protein and glycosaminoglycan biosynthesis analyses
3H-proline and 3 5S-sulfate are commonly used as radiolabels in cartilage research
to observe protein and glycosaminoglycan (GAG) synthesis rates, respectively. Proline
and sulfate isotopes were chosen due to the biochemical composition of the cartilage
extracellular matrix. A primary component of the extracellular matrix, Type II collagen,
is comprised of a significant amount of proline [ref]. With the presence of 3H-proline in
the media, the radioactive marker is incorporated into the new collagen and all other
proline-containing proteins in the matrix. Previous studies showed that ~75% of 3H-
proline was incorporated into collagen in newborn calf cartilage [15]. Similarly, the
composition of the GAG side chains of proteoglycans is dominated by chondroitin sulfate
and keratin sulfate. The incorporation of the radiolabeled sulfate enables a method to
quantify the amount of GAG synthesized during the radiolabel incubation period. A high
rate of radiolabel incorporation, either 3H-proline or 3 5S-sulfate, signifies a high rate of
extracellular matrix biosynthesis in the cartilage plugs. In addition, the incorporation
rates of both radiolabels should be correlated.
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Radiolabel incorporation, wash, and plug digestion
Immediately, following the completion of the compression protocol, the cartilage
plugs of both the control and experimental groups were radiolabeled and assayed for
marker incorporation. The radiolabels, L-3H-proline and sodium 35S-sulfate were added
to the respective feeding media to create radioactive media at concentrations of 10
ptCi/mL 3 5S-sulfate and 20 ptCi/mL 3H-proline or twice that in specific experiments
(experiments with short radiolabel incubation periods). 0.5 mL of the radiolabeled media
was added to each plug in a 48-well plate and incubated for Tiabel hours (1, 2, 4, or 24
hours, depending on experiment).
After the incubation period, the plugs were washed in cold PBS solution
containing 0.4 mM L-proline and 0.8 nM sodium sulfate. Following the removal of the
radioactive media, the plugs were each washed 4 times for a period of 15 minutes per
wash, replacing the 1.0 mL of fresh cold PBS solution per plug per wash. Next the plugs
were placed in individually labeled screw topped vials. Finally, 1.0 mL of a proteinase K
digest solution (0.2 mg/mL proteinase K in Tris-HCl buffer) was added to each plug and
allowed to digest overnight at 55C overnight. A more detailed version of this protocol
can be found in Appendix B.
Liquid scintillation counting
A liquid scintillation counter (RackBeta 1211, LKB) was used to measure the
amount of radiolabeled markers present in the digested cartilage samples. 20 IL aliquots
of radiolabel standards and 100 tL aliquots of cartilage samples were mixed with 2 mL
of scintillation fluid per sample in scintillation vials. Each sample was analyzed by the
counter for 3 minutes.
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Natural radioactive decay in the vials causes an emission of light ("scintillation")
due to components of the scintillation fluid. Each scintillation event is counted by a
photomultiplier in the scintillation counter. Different radioisotopes scintillate at different
wavelengths of light; thus, the detection of multiple isotopes requires the use of different
ranges of minimum and maximum wavelengths. In general, following the detection of an
emission event within a specific range, or "window", the count for that range is
incremented.
Dual radiolabel incorporation rate determination
During the liquid scintillation counting procedure, the two radiolabels, 3H-proline
and 3 5S-sulfate, have emission spectra that overlap (crossover) in their respective
counting spectral windows. Empirically, the overlap of 35S-sulfate label dominates that
of the 3H-proline label; thus, it is sufficient to consider only the 3 5S-sulfate crossover.
Figure 2.7 illustrates the dual radiolabel emission spectra and the two counting windows,
WI and W2.
Liquid Scintillation Counting -Spectral Windows
3 H Spectra 35 S Spectra
0 20 40 60 80 100 120 140 160
W1 W2
Figure 2.7. Spectral windows in liquid scintillation counting.
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In order to determine the crossover ratio for the 3 5S-sulfate label, two sets of 20
pL standards were counted: 1) 35S only and 2) 35S + 3H. To calculate the radiolabel
incorporation rates, 100 pL of each sample were also counted. Table 2.1 shows the
measured values of the two standards and a sample in each window, in terms of the
variables Si, S2, SH1, SH2, A1, and A2.
Table 2.1. Key to measured variable values for radiolabel incorporation rate calculations.
Isotope W1 [CPM] W2 [CPM]
35s Si S2
+ 3H1 SHI SH2
Sample A Al A2
The crossover ratio, X, is defined in Equation 1 as the CPM of S in Window 1
divided by the CPM of S in Window 2:
X = S1/S2 [Eq. 1]
Next, the total S, Stot, and total H, Htot, can be calculated via Equations 2 and 3 as
follows:
Stot =S2+S2.X=S2.(1+X) [CPM] [Eq. 2]
HtOt =SH1-S2-X [CPM] [Eq. 3]
Equations 4-9 define parameters previously measured, empirically determined, or
intrinsic to a given experiment:
PAF a proline activity factor = 5 .105 [pmol]
SAF = sulfate activity factor = 8.2 .105 pmol]
[Eq. 4]
[Eq. 5]
A DNA DNAin Sample A [pg DNA] [Eq. 6]
Tiael =total radiolabel time [hr] [Eq. 7]
VSd std.volume = 20 [pL] [Eq. 8]
Vsamp samplevolume = 100 [aLL] [Eq. 9]
Then the total 3H and 35S counts for Sample A, AH,tot and Astot, respectively, are
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calculated from Equations 10 and 11:
AH,tot =Al -A2-X [CPM] [Eq.10]
AsIot =A2+A2.X=A2.(1+X) [CPM] [Eq.11]
Finally, the 3H and 35S radiolabel incorporation rates for Sample A, RH and Rs,
respectively, are given by Equations 12 and 13.
AH,tot -PAF V pmol proline
RH ,t,, * ADNA *Tlabel samp _ pgDNA-hr _
Asat * SAF -V PM 1 su1fate
RS [Eq. 13]
S,, * ADNA Tlabel samp _pg DNA -hr
2.4.2 Glycosaminoglycan content assay
Proteoglycans are macromolecules containing glycosaminoglycan (GAG) side
chains of fixed negative charges; aggrecan is the predominant GAG-bearing proteoglycan
of cartilage. The sulfated glycosaminoglycan content of each plug was measured using
the DMMB dye assay described previously [15]. GAG standards of known
concentrations were prepared by serial dilutions in Tris-HCl. 20 ptL of each sample or
standard was aliquoted into a 96 well plate. 200 pL of DMMB dye was then added to
each sample, taking care to eliminate pockets of air. The light absorbance for each
sample was measured by the use of a plate-reading spectrophotometer (Vmax kinetic
microplate reader, Molecular Devices). Using the readings from the known GAG
standards, the GAG concentrations of the samples were calculated. A side study was also
conducted to determine the precision and efficacy of the GAG content assay in the
context of this long-term dynamic compression treatment protocol. Appendix A
describes the protocol and the results of the side study. A more detailed version of the
GAG assay protocol can be also found in Appendix B.
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The measured GAG concentrations were used as a measure of proteoglycan
synthesis and extracellular matrix activity. For example, low levels of GAG in a sample
plug may have indicated a loss of proteoglycans from the extracellular matrix to the
media. GAG levels in control and experimental groups may have given an indication of
long-term changes or remodeling in the extracellular matrix due to the dynamic
stimulation protocol or changes in media composition. Furthermore, increased GAG
levels indicated higher levels of proteoglycan synthesis, which may be corroborated by
the results of the radiolabel biosynthetic rate assays described below.
2.4.3 DNA content assay
The DNA content of each plug was measured using the Hoechst dye assay
described previously [15]. DNA standards of known concentrations were prepared by
serial dilutions in Tris-HCl. 20 pL of each sample or standard was aliquoted into a 96
well plate. 200 pL of Hoechst dye was then added to each sample, taking care to
eliminate pockets of air. The fluorescence due to ultraviolet light stimulation for each
sample was measured by the use of a plate-reading spectrofluorometer (Victor). Using
the readings from the known DNA standards, the DNA concentrations of the samples
were calculated. A side study was also conducted to determine the precision and efficacy
of the DNA content assay in the context of this long-term dynamic compression
treatment protocol. Appendix A describes the protocol and the results of the study. A
more detailed version of the DNA assay protocol can be found in Appendix B.
The measured DNA contents were an indication of the number of viable cells in
the sample tissue because chondrocytes maintain their DNA until their nuclei are cleaved,
as in apoptosis. Thus, a significantly reduced level of DNA content in a sample indicated
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a loss of chondrocytes due to some experimental condition. The DNA contents allowed
the biosynthesis rates of each sample to be normalized to cell number via the DNA
content and enabled the samples to be compared statistically.
2.5 Medium comparison
In order to isolate the effects of the growth factor IGF-I, the feeding medium for
the cartilage plugs must be free of other growth factors. Because the FBS in the regular
feeding medium contains natural growth factors, it was necessary to investigate the use of
a 'serum-free" medium for feeding. In this protocol, FBS was replaced by ITS, as was
done in previous IGF-I experiments and the effects of the media change was observed in
conjunction with the dynamic compression.
In addition, the ascorbate in the regular feeding medium is known to break down
after 48 hours, one factor leading to the medium change every 2 days in the protocol.
However, Clark et al. have demonstrated that ascorbyl-2-phosphate (A2P), a different
ascorbic acid compound that is stable over significantly longer periods of time, can
replace the typical ascorbate (L-ascorbic acid) in the feeding medium of guinea pig
articular cartilage explants [14]. In this protocol, the effects of replacing the normal
ascorbate with A2P were observed in several experiments, with the goal of demonstrating
the efficacy and practicality of using more stable feeding medium components due to the
long-term nature of the protocol in general, as well as saving time and cost in medium
preparation.
2.6 Statistical analyses
Statistical Analyses were performed using Microsoft EXCEL (with the Analysis
ToolPak) and Mathworks MATLAB. Standard curves for the photometric GAG and
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fluorometric DNA data were constructed by statistical curve-fitting functions. The
standard curves were used to convert the measured assay data into ug/mL GAG or DNA
present in the digested cartilage plug solutions. Liquid scintillation count data were
converted into biosynthetic incorporation rates as described above. Then calculated total
DNA data were used to normalize the GAG and biosynthetic incorporation rate data for
each plug.
Within each experiment, data for each experimental condition were reported as
the mean (size N plugs) ± standard error. Finally, Student T-tests or multifactorial
analyses of variance (ANOVA) [16] were then performed to examine the effects of
independent experimental parameters (dynamic compression or variable media).
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Chapter 3 - Results
3.1 Overall Experiment Parameters
Table 3.1 shows a summary of the
Table 3.1. Experimental Parameters Summary.
Summary
parameters of each experiment.
Experiments
1 2 3 4 5 6 7 8
Conditions Free Swell vs. DC x x x x x X X x
Regular vs. ITS Media x x
Regular vs. A2P Media x
Regular vs. ITS-A2P Media x
Radiolabel Period 1 Hour Timepoint x x x
2 Hour Timepoint xx x x x x
4 Hour Timepoint x
24 Hour Timepoint x x x
Compression Days 4 Day x x x x x x x
6 Day x
Slice Preference Nearest to surface x x x x
Nearest to 1 mm x I _ X x x
3.2 Experiment 1
Design
During the explant procedure, 6 cartilage slices were obtained from one joint.
The slices taken closer to the superficial core surface were chosen over those that were
deeper and more vascularized. The cartilage plugs were all fed with the regular medium.
One group of plugs (Control) was allowed to remain in free swell conditions. Another
group of plugs (DC) was mechanically loaded using the dynamic compression protocol
over 4 compression days. From each slice, one plug went into the Control group and one
plug went into the DC group. The remaining two plugs per slice were not used.
Following the loading protocol, the plugs were radiolabeled for 24 hours. There were a
total of 2 experimental groups (Control, DC) with N = 6. Details of the experimental
design are found in Appendix C.
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Assays
Figure 3.1 a shows the results of the sulfate incorporation (mean ± SEM) assay.
Figure 3. lb shows the results of the proline incorporation (mean ± SEM) assay. Figure
3.1 c shows the results of the total GAG (mean ± SEM) assay. The experiment did not
demonstrate significant statistical differences (p > 0.05) in any of the three assays.
Details of the data and analyses of the assays are found in Appendix C.
Experiment 1 (24 Hr) Sulfate Inc.
z0
E
0.
2
1.5
1
0.5
0
T
DCControl
T
Figure 3.a. Experiment 1 (24 hour): rate of 3 5S-sulfate incorporation (mean ± SEM).
Experiment 1 (24 hr) Proline Inc.
25 -
z
o15
S10
05
E
Control DC
Figure 3.1b. Experiment 1 (24 hour): rate of 3H-proline incorporation (mean SEM).
24
--
Experiment 1 (24 hr) GAG
250
200 -
z
c150 -
0
0
<100
Control DC
Figure 3.1c. Experiment 1 (24 hour): total GAG content (mean SEM).
3.3 Experiment 2
Design
During the explant procedure, 9 cartilage slices were obtained from one joint.
The slices taken closer to the superficial core surface were chosen over those that were
deeper and more vascularized. The cartilage plugs were all fed with the regular medium.
Three groups of plugs (Control) were allowed to remain in free swell conditions.
Another three groups of plugs (DC) were mechanically loaded using the dynamic
compression protocol with 4 compression days. Two groups each (four total) of the
Control and DC groups were obtained from the first 5 slices, and the other Control and
DC groups (remaining two) were obtained from the remaining 4 slices. Following the
loading protocol, the plugs were radiolabeled for 24 hours. The plugs were then pooled
together for a total of 2 experimental groups (Control, DC) with N = 14. The goal of this
experiment was to repeat Experiment 1 with a larger data set. Details of the experimental
design are found in Appendix C.
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Assays
Figure 3.2a shows the results of the sulfate incorporation (mean +/- SEM) assay.
The sulfate incorporation in the DC group was 1.61 times that of the Control group with
p < 0.05 (Student T test). Figure 3.2b shows the results of the total GAG (mean +/-
SEM) assay. The experiment did not demonstrate significant statistical differences (p <
0.05) in the total GAG assays between the experimental groups. The proline
incorporation data was not included here. Details of the data and analyses of the assays
are found in Appendix C.
Experiment 2 (24 hr) Sulfate Inc.
40
350.05
z 30
0
0 5E
- 0
Control DC
Figure 3.2a. Experiment 2 (24 hour): rate of 35S-sulfate incorporation (mean SEM). (*: statistically
different, p < 0.05).
Experiment 2 (24 hr) GAG
70
60
50 -
0D 30
10
0
Control DC
Figure 3.2b. Experiment 2 (24 hour): total GAG content (mean SEM).
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3.4 Experiment 3
Design
During the explant procedure, 6 cartilage slices were obtained from one joint.
The slices taken closer to the superficial core surface were chosen over those that were
deeper and more vascularized. The cartilage plugs were all fed with the regular medium.
Three groups of plugs (Control) were allowed to remain in free swell conditions.
Another three groups of plugs (DC) were mechanically loaded using the dynamic
compression protocol with 4 compression days. Two slices were used per Control and
DC group, with two plugs per slice going to each group. Following the loading protocol,
each set of the Control and DC groups was radiolabeled for 1, 2, or 4 hours. The groups
at each time point were analyzed as 3 separate experiments of 2 experimental groups
(Control, DC) with N = 4. The goal of this experiment was to repeat Experiments 1 and
2 with different radiolabel times. Details of the experimental design are found in
Appendix C.
Assays
I. Tiabei = 1 hour
Figure 3.3a shows the results of the sulfate incorporation (mean ± SEM) assay.
The sulfate incorporation in the DC group was 1.618 times that of the Control group
indicating a trend towards increased synthesis caused by compression. However, T-test
analysis indicated that this trend did not quite reach statistical significance (p = 0.083).
Figure 3.3b shows the results of the total GAG (mean ± SEM) assay. While the total
GAG in the DC group was 3.00 times that of the Control group, T-test analysis indicates
that the difference in total GAG is not statistically significant. The proline incorporation
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data was not included here. Details of the data and analyses of the assays are found in
Appendix C.
Experiment 3 (1 hr) Sulfate Inc.
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Figure 3.3a. Experiment 3 (1 hour): rate of 35S-sulfate incorporation (mean ± SEM).
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Figure 3.3b. Experiment 3
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(1 hour): total GAG content (mean ± SEM). (*: statistically different, p <
II. Tlabei = 2 hours
Figure 3.4a shows the results of the sulfate incorporation (mean ± SEM) assay.
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The sulfate incorporation in the DC group was similar to that of the Control group and T-
test analysis indicates that the difference is not statistically different (p = 0.773). Figure
3.4b shows the results of the total GAG (mean ± SEM) assay. Again, the T-test analysis
indicates that the difference in total GAG between the DC and Control groups is not
statistically significant. The proline incorporation data was not included here. Details of
the data and analyses of the assays are found in Appendix C.
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Figure 3.4a. Experiment 3 (2 hour): rate of 3 5S-sulfate incorporation (mean SEM).
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Figure 3.4b. Experiment 3 (2 hour): total GAG content (mean ± SEM).
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III. Tiabei = 4 hours
Figure 3.5a shows the results of the sulfate incorporation (mean ± SEM) assay.
The sulfate incorporation in the DC group was 3.11 times that of the Control group and
T-test analysis indicates that the difference is statistically different (p < 0.05). Figure
3.5b shows the results of the total GAG (mean ± SEM) assay. The total GAG in the DC
group was 2.97 times that of the Control group and T-test analysis again indicates that the
difference is statistically different (p < 0.05). The proline incorporation data was not
included here. Details of the data and analyses of the assays are found in Appendix C.
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Figure 3.5a. Experiment 3 (4 hour): rate of 35S-sulfate incorporation (mean SEM). (*: statistically
different, p < 0.05).
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Figure 3.5b. Experiment 3 (4 hour): total GAG content (mean ± SEM). (*: statistically different, p <
0.05).
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3.5 Experiment 4
Design
During the explant procedure, 4 cartilage slices were obtained from one joint.
The slices taken closer to the superficial core surface were chosen over those that were
deeper and more vascularized. The joint used in this experiment was fairly small and
results in a very small yield of cartilage. The cartilage plugs were all fed with the regular
medium. Two groups of plugs (Control) were allowed to remain in free swell conditions.
Another two groups of plugs (DC) were mechanically loaded using the dynamic
compression protocol with 4 compression days. In this experiment, two slices were used
for each set of Control and DC groups. From each slice, one plug went into the Control
group and the remaining three plugs went into the DC group. Following the loading
protocol, each set of the Control and DC groups was radiolabeled for 1 or 2 hours using
twice the typical concentration of radiolabels as before. During the experiment, some
plugs were lost in handling. The groups at each time point were analyzed as 2 separate
experiments of 2 experimental groups with N = 2 (Control) and N = 5 or 6 (DC). The
goal of this experiment was to repeat a portion of Experiment 3 with twice the
concentration of radioactive labels. Details of the experimental design are found in
Appendix C.
Assays
I. Tiabel = 1 hour
Figure 3.6a shows the results of the sulfate incorporation (mean ± SEM) assay.
Figure 3.6b shows the results of the proline incorporation (mean ± SEM) assay. Figure
3.6c shows the results of the total GAG (mean ± SEM) assay. While the mean of the DC
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group was greater than those of the Control group for each assay, the experiment did not
demonstrate significant statistical differences (p > 0.05) between the Control and DC
groups in any of the three assays. Details of the data and analyses of the assays are found
in Appendix C.
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Figure 3.6a. Experiment 4 (1 hour): rate of 3 5S-sulfate incorporation (mean ± SEM).
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Figure 3.6b. Experiment 4 (1 hour): rate of 3H-proline incorporation (mean ± SEM).
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Figure 3.6c. Experiment 4 (1 hour): total GAG content (mean SEM).
II. Tiabei = 2 hour
Figure 3.7a shows the results of the sulfate incorporation (mean +/- SEM) assay.
Figure 3.7b shows the results of the proline incorporation (mean +/- SEM) assay. Figure
3.7c shows the results of the total GAG (mean +/- SEM) assay. Again, while the mean of
the DC group was greater than those of the Control group for each assay, the experiment
did not demonstrate significant statistical differences (p > 0.05) between the Control and
DC groups in any of the three assays. Details of the data and analyses of the assays are
found in Appendix C.
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Figure 3.7a. Experiment 4 (2 hour): rate of 3 5S-sulfate incorporation (mean ± SEM).
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Figure 3.7b. Experiment 4 (2 hour): rate of 3H-proline incorporation (mean ± SEM).
Figure 3.7c. Experiment 4 (2 hour): total GAG content (mean ± SEM).
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3.6 Experiment 5
Design
During the explant procedure, 12 cartilage slices were obtained from two joints.
The slices from both joints were pooled, measured, and sorted by height measured by a
digital caliper. The 12 slices nearest to 1.00 mm were chosen for the experiment. The
cartilage plugs were all fed with the regular medium. Four groups of plugs (Control)
were allowed to remain in free swell conditions. Another Four groups of plugs (DC)
were mechanically loaded using the dynamic compression protocol with 4 compression
days. 6 slices were used per two sets of Control and DC group, with one plug per slice
going to each group of each set. Following the loading protocol, each of the 4 sets of the
Control and DC groups was radiolabeled for 1, 2, 4, or 24 hours using twice the typical
concentration of radiolabels. The groups at each time point were analyzed as 4 separate
experiments of 2 experimental groups (Control, DC) with N = 6. The goal of this
experiment was to repeat Experiment 4 with a larger yield of cartilage. Details of the
experimental design are found in Appendix C.
Assays
I. Tabel =1 hour
Figure 3.8a shows the results of the sulfate incorporation (mean ± SEM) assay.
The sulfate incorporation in the DC group was 1.18 times that of the Control group
indicating a trend towards increased synthesis caused by compression. However, T-test
analysis indicated that this trend did not quite reach statistical significance (p = 0.073).
Figure 3.8b shows the results of the proline incorporation (mean ± SEM) assay. The
proline incorporation in the DC group was 1.47 times that of the Control group and T-test
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analysis indicates that the difference is statistically different (p < 0.05). Figure 3.8c
shows the results of the total GAG (mean ± SEM) assay. While the total GAG in the DC
group was 1.14 times that of the Control group, ANOVA analysis indicates that the
difference total in GAG is not statistically significant (p > 0.05). Details of the data and
analyses of the assays are found in Appendix C.
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Experiment 5 (1 hour): rate of 3 5S-sulfate incorporation (mean ± SEM).
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Figure 3.8b. Experiment 5 (1 hour): rate of 3H-proline incorporation (mean ± SEM). (*, +: statistically
different, p < 0.05).
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Figure 3.8c. Experiment 5 (1 hour): total GAG content (mean ± SEM).
II. Tiabe = 2 hour
Figure 3.9a shows the results of the sulfate incorporation (mean SEM) assay.
While the sulfate incorporation in the DC group was 1.09 times that of the Control group,
ANOVA analysis indicates that the difference is not statistically different (p > 0.05).
Figure 3.9b shows the results of the proline incorporation (mean ± SEM) assay. The
proline incorporation in the DC group was 1.28 times that of the Control group indicating
a trend towards increased synthesis caused by compression. However, T-test analysis
indicated that this trend did not quite reach statistical significance (p = 0.093). Figure
3.9c shows the results of the total GAG (mean ± SEM) assay. While the total GAG in the
DC group was actually smaller than that of the Control group, T-test analysis indicates
that the difference in total GAG is not statistically significant (p > 0.05). Details of the
data and analyses of the assays are found in Appendix C.
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Experiment 5 (2 hour): rate of 3 5S-sulfate incorporation (mean ± SEM).
Experiment 5 (2 hour): rate of 3H-proline incorporation (mean ± SEM).
Experiment 5 (2 hr) GAG
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Figure 3.9c. Experiment 5 (2 hour): total GAG content (mean ± SEM).
DC
III. Tiabei= 4 hour
The data for this experiment is not shown because of problems in the DNA
content assay. The sulfate and proline incorporations and the total GAG content data
could not be properly normalized to the DNA data.
IV. Tiabel = 24 hour
Figure 3.1 0a shows the results of the sulfate incorporation (mean ± SEM) assay.
While the sulfate incorporation in the DC group was 1.20 times that of the Control group,
T-test analysis indicates that the difference is not statistically different (p > 0.05).
Figure 3.1 Ob shows the results of the proline incorporation (mean ± SEM) assay.
While the proline incorporation in the DC group was actually smaller than that of the
Control group, T-test analysis indicates that the difference in the incorporation is not
statistically significant (p > 0.05). Figure 3.10c shows the results of the total GAG (mean
+ SEM) assay. The total GAG in the DC group was 1.23 times that of the Control group
and T-test analysis indicates that the difference is statistically different (p < 0.05).
Details of the data and analyses of the assays are found in Appendix C.
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Figure 3.10a. Experiment 5 (24 hour): rate of 35S-sulfate incorporation (mean SEM).
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Figure 3.10b. Experiment 5 (24 hour): rate of 3H-proline incorporation (mean ± SEM).
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Figure 3.10c. Experiment 5 (24 hour): total GAG content (mean ± SEM). (*: statistically different, p <
0.05).
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3.7 Experiment 6
Design
During the explant procedure, 12 cartilage slices were obtained from two joints.
The slices from both joints were pooled, measured, and sorted by height measured by a
digital caliper. The 12 slices nearest to 1.00 mm were chosen for the experiment. The
cartilage plugs were fed with the regular medium (R), medium with ascorbate replaced by
acorbyl-2-phosphate (A), or medium with FBS replaced by ITS (I). Half of the plugs
within each medium group were allowed to remain in free swell conditions and the
remaining plugs (DC) were mechanically loaded using the dynamic compression protocol
with 6 compression days. 6 slices were used per set of free swell/DC/regular
medium/experimental medium plugs (I or A), with one plug per slice going to each
experimental condition. Following the loading protocol, the samples were radiolabeled
for 2 hours using twice the typical concentration of radiolabels. The plugs were analyzed
as 2 separate experiments of 4 experimental groups (R/R-DC/I/I-DC and R/R-DC/A/A-
DC) with N = 6. The goal of this experiment was to examine the effects of replacing
FBS and ascorbate in the media with ITS and A2P, respectively, as well as to continue to
observe the effects of the compression protocol on the plugs. Details of the experimental
design are found in Appendix C.
Assays
I. Regular vs. ITS Media
Figure 3.11 a shows the results of the sulfate incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 2.29. For the other two groups (I,
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I-DC) in the ITS medium, the corresponding ratio was 0.94. For the two free swell
groups (R, I), the ratio of the I group over the R group was 2.59. For the other two
groups (R-DC, I-DC) the corresponding ratio was 1.07. The two factor ANOVA analysis
(R vs. I and free swell vs. DC) indicated statistical differences (p < 0.05) for the data due
to the two media, the compression protocol, and the interaction between both factors.
Figure 3.11 b shows the results of the proline incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 1.54. For the other two groups (I,
I-DC) in the ITS medium, the corresponding ratio was 1.13. For the two free swell
groups (R, I), the ratio of the I group over the R group was 1.42. For the other two
groups (R-DC, I-DC) the corresponding ratio was 1.05. The two factor ANOVA analysis
(R vs. I and free swell vs. DC) indicated a statistical difference (p < 0.05) for the data due
to the compression protocol, but not due to the media or the interaction between both
factors (p > 0.05).
Figure 3.11 c shows the results of the total GAG (mean ± SEM) assay for the
experimental conditions. For the two groups in the regular medium (R, R-DC), the ratio
of the DC group over the free swell group was 1.15. For the other two groups (I, I-DC)
in the ITS medium, the corresponding ratio was 0.95. For the two free swell groups (R,
I), the ratio of the I group over the R group was 1.20. For the other two groups (R-DC, I-
DC) the corresponding ratio was 0.98. The two factor ANOVA analysis (R vs. I and free
swell vs. DC) indicated no statistical differences (p > 0.05) for the data due to the media,
the compression protocol, or the interaction between both factors. Details of the data and
analyses of the three assays are found in Appendix C.
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Figure 3.11a. Experiment 6 (2 hour, Regular vs. ITS media): rate of
SEM). (*: statistically different, p < 0.05).
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Figure 3.1 1c. Experiment 6 (2 hour, Regular vs. ITS media): total GAG content (mean ± SEM).
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II. Regular vs. A2P Media
Figure 3.12a shows the results of the sulfate incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 2.24. For the other two groups
(A, A-DC) in the A2P medium, the corresponding ratio was 1.72. For the two free swell
groups (R, A), the ratio of the A group over the R group was 1.22. For the other two
groups (R-DC, A-DC) the corresponding ratio was 0.94. The two factor ANOVA
analysis (R vs. A and free swell vs. DC) indicated a statistical difference (p < 0.05) for
the data due to the compression protocol, but not due to the media or the interaction
between both factors (p > 0.05).
Figure 3.12b shows the results of the proline incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 1.54. For the other two groups
(A, A-DC) in the A2P medium, the corresponding ratio was 1.20. For the two free swell
groups (R, A), the ratio of the A group over the R group was 1.17. For the other two
groups (R-DC, A-DC) the corresponding ratio was 0.91. The two factor ANOVA
analysis (R vs. A and free swell vs. DC) indicated a statistical difference (p < 0.05) for
the data due to the compression protocol, but not due to the media or the interaction
between both factors (p > 0.05).
Figure 3.12c shows the results of the total GAG (mean ± SEM) assay for the
experimental conditions. For the two groups in the regular medium (R, R-DC), the ratio
of the DC group over the free swell group was 1.40. For the other two groups (A, A-DC)
in the A2P medium, the corresponding ratio was 1.26. For the two free swell groups (R,
44
A), the ratio of the A group over the R group was 1.00. For the other two groups (R-DC,
A-DC) the corresponding ratio was 0.90. The two factor ANOVA analysis (R vs. A and
free swell vs. DC) indicated a statistical difference (p < 0.05) for the data due to the
compression protocol, but not due to the media or the interaction between both factors (p
> 0.05). Details of the data and analyses of the three assays are found in Appendix C.
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Figure 3.12a. Experiment 6 (2 hour, Regular vs. A2P media): rate of 31S-sulfate incorporation (mean
SEM). (*, +: statistically different, p < 0.05).
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Figure 3.12b. Experiment 6 (2 hour, Regular vs. A2P media): rate of 3H-proline incorporation (mean
SEM). (*, +: statistically different, p < 0.05).
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Figure 3.12c. Experiment 6 (2 hour, Regular vs. A2P media): total GAG content (mean SEM). (*, +:
statistically different, p < 0.05).
3.8 Experiment 7
Design
During the explant procedure 12 cartilage slices were obtained from two joints.
The slices from both joints were pooled, measured, and sorted by height measured by a
digital caliper. The 12 slices nearest to 1.00 mm were chosen for the experiment. The
cartilage plugs were fed with the regular medium (R) and medium with FBS replaced by
ITS (I). Half of the plugs within each medium group were allowed to remain in free
swell conditions and the remaining plugs (DC) were mechanically loaded using the
dynamic compression protocol with 6 compression days. One plug per slice was used for
each experimental condition. Following the loading protocol, the samples were
radiolabeled for 2 hours using the typical concentration of radiolabels. One set of plugs
was lost during the protocol, so the plugs were analyzed as one set of 4 experimental
groups (R/R-DC/I/I-DC) with N = 11. The goal of this experiment was to repeat the
regular vs. ITS media portion of Experiment 6. Details of the experimental design are
found in Appendix C.
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Assays
Figure 3.13a shows the results of the sulfate incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 1.57. For the other two groups (I,
I-DC) in the ITS medium, the corresponding ratio was 0.72. For the two free swell
groups (R, I), the ratio of the I group over the R group was 2.08. For the other two
groups (R-DC, I-DC) the corresponding ratio was 0.95. The two factor ANOVA analysis
(R vs. I and free swell vs. DC) indicated statistical differences (p < 0.05) for the data due
to the two media and the interaction between both factors, but not due to the compression
protocol alone (p > 0.05).
Figure 3.13b shows the results of the proline incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 1.37. For the other two groups (I,
I-DC) in the ITS medium, the corresponding ratio was 0.75. For the two free swell
groups (R, I), the ratio of the I group over the R group was 1.86. For the other two
groups (R-DC, I-DC) the corresponding ratio was 1.01. Again, the two factor ANOVA
analysis (R vs. I and free swell vs. DC) indicated statistical differences (p < 0.05) for the
data due to the two media and the interaction between both factors, but not due to the
compression protocol alone (p > 0.05).
The total GAG content data was not shown here. Details of the data and analyses
of the three assays are found in Appendix C.
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Figure 3.13a. Experiment 7 (2 hour, Regular vs. ITS media): rate of 31S-sulfate incorporation (mean
SEM). (*: statistically different, p <0.05).
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Figure 3.13b. Experiment 7 (2 hour, Regular vs. ITS media): rate of 3H-proline incorporation (mean
SEM). (*: statistically different, p < 0.05).
3.9 Experiment 8
Design
During the explant procedure, 12 cartilage slices were obtained from two joints.
The slices from both joints were pooled, measured, and sorted by height measured by a
digital caliper. The 12 slices nearest to 1.00 mm were chosen for the experiment. The
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cartilage plugs were fed with the regular medium (R) and medium with both FBS
replaced by ITS and ascorbate replaced by A2P (IA). Half of the plugs within each
medium group were allowed to remain in free swell conditions and the remaining plugs
(DC) were mechanically loaded using the dynamic compression protocol with 6
compression days. One plug per slice was used for each experimental condition.
Following the loading protocol, the samples were radiolabeled for 2 hours using the
typical concentration of radiolabels. The plugs were not labeled with proline in this
experiment. The plugs were analyzed as two set of 4 experimental groups (R/R-
DC/IA/IA-DC) with N = 6 for both sets. The goal of this experiment was to examine the
effects of replacing both FBS and ascorbate in the media with both ITS and A2P,
simultaneously, as well as to continue to observe the effects of the compression protocol
on the plugs. Details of the experimental design are found in Appendix C.
Assays
I. Regular vs. ITS-A2P Media, Set 1
Figure 3.14a shows the results of the sulfate incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 0.16. For the other two groups
(IA, IA-DC) in the ITS-A2P medium, the corresponding ratio was 0.14. For the two free
swell groups (R, IA), the ratio of the IA group over the R group was 1.22. For the other
two groups (R-DC, IA-DC) the corresponding ratio was 1.06. The two factor ANOVA
analysis (R vs. IA and free swell vs. DC) indicated statistical differences (p < 0.05) for
the data due to the compression protocol, but not due to the two media or the interaction
between both factors (p > 0.05).
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Figure 3.14b shows the results of the total GAG (mean ± SEM) assay for the
experimental conditions. For the two groups in the regular medium (R, R-DC), the ratio
of the DC group over the free swell group was 1.10. For the other two groups (IA, IA-
DC) in the ITS-A2P medium, the corresponding ratio was 1.02. For the two free swell
groups (R, IA), the ratio of the IA group over the R group was 1.01. For the other two
groups (R-DC, IA-DC) the corresponding ratio was 0.93. The two factor ANOVA
analysis (R vs. I and free swell vs. DC) indicated no statistical differences (p > 0.05) for
the data due to the two media, the compression protocol, or the interaction between both
factors. Details of the data and analyses of the three assays are found in Appendix C.
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Figure 3.14a. Experiment 8 (2 hour, Regular vs. ITS-A2P media Set 1): rate of 35S-sulfate incorporation
(mean ± SEM). (*: statistically different, p < 0.05).
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Figure 3.14b. Experiment 8 (2 hour, Regular vs. ITS-A2P media Set 1): total GAG content (mean ±
SEM).
II. Regular vs. ITS-A2P Media, Set 2
Figure 3.15a shows the results of the sulfate incorporation (mean ± SEM) assay
for the experimental conditions. For the two groups in the regular medium (R, R-DC),
the ratio of the DC group over the free swell group was 0.97. For the other two groups
(IA, IA-DC) in the ITS-A2P medium, the corresponding ratio was 0.98. For the two free
swell groups (R, IA), the ratio of the IA group over the R group was 1.04. For the other
two groups (R-DC, IA-DC) the corresponding ratio was 1.05. The two factor ANOVA
analysis (R vs. IA and free swell vs. DC) indicated no statistical differences (p > 0.05) for
the data due to the two media, the compression protocol, or the interaction between both
factors.
Figure 3.15b shows the results of the total GAG (mean ± SEM) assay for the
experimental conditions. For the two groups in the regular medium (R, R-DC), the ratio
of the DC group over the free swell group was 0.84. For the other two groups (IA, IA-
DC) in the ITS-A2P medium, the corresponding ratio was 0.95. For the two free swell
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groups (R, IA), the ratio of the IA group over the R group was 0.72. For the other two
groups (R-DC, IA-DC) the corresponding ratio was 0.81. The two factor ANOVA
analysis (R vs. I and free swell vs. DC) indicated no statistical differences (p > 0.05) for
the data due to the two media, the compression protocol, or the interaction between both
factors.
Details of the data and analyses of the three assays are found in Appendix C.
Experiment 8 - Regular vs. ITS-A2P Media, Set 2
(2 hr) Sulfate Inc.
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Figure 3.15a. Experiment 8 (2 hour, Regular vs. ITS-A2P media Set 2): rate of 3 S-sulfate incorporation
(mean ± SEM).
Experiment 8 - Regular vs. ITS-A2P Media, Set 2
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Figure 3.15b. Experiment 8 (2 hour, Regular vs. ITS-A2P media Set 2): total GAG content (mean ±
SEM).
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Chapter 4 - Discussion
4.1 Free swell vs. dynamic compression
The primary goal of the series of experiments was to demonstrate the effects of an
extended mechanical loading protocol on articular cartilage explants. Experiments 1-8 all
tested plugs in the regular medium in free swell versus loaded conditions. Throughout
the course of the experiments, the depths from which the cartilage slices were obtained,
the radiolabel time points following the compression protocol, and the number of
compression/rest days in the protocol were varied.
In Experiments 1-4, the cartilage slices were taken as near to the femoropatellar
groove surface as possible after slicing with the microtome. In Experiment 1, the T-test
analyses of the assays indicated nothing conclusive could be made concerning the effects
of the loading from the experiment, which led to a repeat of the experiment with a larger
N size in Experiment 2. In Experiment 2, the T-test analysis of the sulfate incorporation
assay indicated a significant effect (p < 0.05) due to the loading (Figure 3.2a). However
a similar effect was not seen in the GAG assay (Figure 3.2b). Experiment 2 indicated
that biosynthesis rates were elevated in the loaded samples in the 24 hours following the
loading, but that the general total synthesis of matrix proteins was not significantly
elevated over the course of the loading protocol. In Experiment 3, shorter radiolabel time
points were chosen to further focus on the biosynthesis rates. Even though, the
biosynthesis rates were not shown to be statistically elevated due to the loading, Figures
3.3a and 3.5a show that the biosynthesis rates for the loaded samples were higher than the
free swell controls. Furthermore, Figures 3.3b and 3.5b also showed a similar increase in
total GAG content for the loaded samples. Because a change in GAG content is a long-
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term response of cartilage to stimuli, this was the first indication that the samples were
responding to the extended loading as predicted. Experiment 4 was designed to be a
repeat of Experiment 3 to verify the positive trends seen previously, but its usefulness
was diminished by the very low yield of cartilage from the harvest. As expected from a
smaller experiment size (N), a higher level of variability was observed in the results as
compared to previous experiments. Although statistical differences due to loading were
not revealed through T-test analyses of the assays, the biosynthetic rates and the GAG
content (Figures 3.6a-3.6c, 3.7a-3.7c) all visually indicate the predicted trend of increased
activity from the dynamic compression over free swell conditions. From the results of
the first four experiments, attempting to obtain the most superficial slices from the cores
seemed to cause an increased level of variability in the data. However, overall the first
four experiments demonstrated encouraging evidence towards demonstrating the validity
of the experimental goal and hypothesis.
In order to address the variability issues raised by taking the more superficial
slices of cores, the harvesting protocol was adjusted to produce more uniform slices
closer to 1 mm in thickness. The adjusted harvesting protocol was used in Experiments
5-8. Experiment 5 repeated Experiment 4 with a larger N size and more uniform plugs.
Again, the results of the experiment demonstrated the positive trends in the increased
biosynthesis rates due to the dynamic compression in three of the radiolabel time points
(Figures 3.8a-3.8b, 3.9a-3.9b, and 3.1Oa). Figure 3.8b showed a statistical significance in
the increased rates due to the compression protocol by T-test analysis (p < 0.05).
Similarly, the positive trend in increased extracellular matrix growth due to loading was
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seen in two of the time points (Figures 3.8c and 3.10c). Figure 3.10c showed a statistical
significance in the GAG content due to the compression by T-test analysis (p < 0.05).
In Experiment 6, the compression protocol was lengthened by two pairs of
compression/rest days for laboratory logistical reasons. Figures 3.1 la-3.1 lb and 3.12a-
3.12b showed statistical differences calculated via T-test and ANOVA (p < 0.05) due to
the compression protocol for biosynthesis rates in the plugs fed by the regular medium in
the Regular vs. ITS media sub-experiment and by the plugs in both the regular and A2P
media in the Regular vs. A2P media sub-experiment. A positive trend was also visually
indicated for the mechanically loaded plugs fed by the ITS medium in the Regular vs.
ITS media sub-experiment. Figure 3.12c showed the statistical differences calculated by
T-test and ANOVA (p < 0.05) in the GAG content for compressed plugs in both regular
and A2P media further indicating increased long-term growth in both media due to the
loading protocol. In Experiment 7, statistical differences were again seen in the
biosynthesis rates via ANOVA analysis (p < 0.05) (Figures 3.13a and 3.13b) indicating
the expected level of increases synthesis following the extended compression protocol.
In Experiment 8, the GAG contents of the plugs fed by regular media in free swell and
compression conditions were statistically equivalent by T-test and ANOVA analysis.
However, the biosynthesis rates for the compressed plugs actually fell significantly (4x)
for one trial (Figure 3.14a) of the experiment while staying the same for the other trial
(Figure 3.15a). Because the GAG contents of the plugs were virtually equivalent, it was
possible that an error was made in the actual biosynthesis assay procedure for the first
trial. It was also possible that during the final compression day in the protocol, the plugs
in the first trial may have been injured (an inadvertently high loading offset prior to the
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sinusoidal compression portion of the protocol) and that there was insufficient time
during the radiolabel time for the GAG to be lost to the media.
4.2 Regular vs. A2P media
A second goal of the experiments was to investigate the effects of replacing the
FBS in the regular feeding medium with A2P in an extended mechanical loading protocol
for articular cartilage explants. Because the normal ascorbate in the regular medium
breaks down within 2 days, the longer lasting A2P was investigated as a source of
acorbate in the feeding medium. Experiment 6 tested plugs in the regular medium as well
as A2P medium for free swell versus loaded conditions. Throughout the course of the
experiments, the adjusted harvesting protocol was used to obtain plugs of thickness near
1 mm.
In Experiment 6, the data from the free swell plugs in both Regular and A2P
media were compared via T-test and ANOVA analysis. The data for the compressed
plugs were also compared in a similar fashion. The biosynthesis rates and the total GAG
content of the free swell plugs were statistically the same for the plugs in both media
(Figures 3.12a - 3.12c). The rates and GAG content were also the same for the
dynamically compressed plugs, indicating any differences between compressed and free
swell plugs were due to the loading protocol and not the media.
4.3 Regular vs. ITS media
A third goal of the experiments was to investigate the effects of replacing the FBS
in the regular feeding medium with ITS in an extended mechanical loading protocol for
articular cartilage explants. Because FBS contains, among other things, various growth
factors, it must be replaced with ITS prior to the study of any other growth factors, such
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as IGF-I. Experiments 6 and 7 tested plugs in both the regular medium and the ITS
medium for free swell versus loaded conditions. Throughout the course of the
experiments, the adjusted harvesting protocol was used to obtain plugs of thickness near
1mm.
In Experiment 6, the data from the free swell plugs in both Regular and ITS media
were compared via T-test and ANOVA analysis. The data for the compressed plugs were
also compared in a similar fashion. The biosynthesis tates and the total GAG content of
the dynamically compressed plugs were statistically the same for the plugs in both media
(Figures 3.1 la - 3.1 1c). However, the free swell plugs fed with ITS medium showed
higher biosynthesis rates and GAG content than the free swell plugs in regular medium,
which was surprising. The data indicates that there was some statistical effect from the
interaction of the medium and the loading protocol in the experiment. Experiment 7
repeated the Regular vs. ITS media sub-experiment with a larger N size. The same
results were seen in Experiment 7 (Figures 3.13a and 3.13b) as in Experiment 6. Again
these were unexpected results because the compressed plugs showed no preference for
feeding medium while the free swell plugs favored the ITS medium for biosynthesis and
matrix growth.
4.4 Regular vs. ITS-A2P media
The final goal of the experiments was to investigate the effects of replacing both
the FBS and the ascorbate in the regular feeding medium with ITS and A2P in an
extended mechanical loading protocol for articular cartilage explants in preparation for a
study of the synergistic effects of extended dynamic compression and IGF-I. Experiment
8 tested plugs in both the regular medium and the ITS-A2P medium for free swell versus
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loaded conditions. Throughout the course of the experiments, the adjusted harvesting
protocol was used to obtain plugs of thickness near 1 mm.
In Experiment 8, the data from the free swell plugs in both Regular and ITS-A2P
media were compared via T-test and ANOVA analysis. The data for the compressed
plugs were also compared in a similar fashion. The total GAG contents of the free swell
plugs were statistically the same for the plugs in both media (Figures 3.14b and 3.15b).
Similarly, the GAG contents were also the same for the dynamically compressed plugs in
both media. The same similarities by medium were seen in the biosynthesis rates for the
plugs (Figures 3.14a and 3.15a) even though the dynamically compressed plugs results in
unexpectedly low synthesis values compared to the free swell plugs, as discussed
previously. The results of Experiment 8 seemed to indicate no long-term differences in
using ITS-A2P media in the extended compression protocol preparation for the addition
of IGF-I for study.
4.5 Variation in assay results
An interesting observation across all the experimental results was that the results
of the assays were consistent within a single experiment, but varied greatly across
separate experiments, sometimes by orders of magnitude. This precluded pooling of data
across separate experiments and led to each experiment being analyzed separately.
Because all the assay data were normalized to the results of the DNA content assay, the
precision of the DNA assay could play a factor in the variability between separate
experiments. Another source of the variability might have arisen from the use of
different lots of various chemicals and materials in the assays (i.e. stock GAG and DNA
standards, radionuclides, dyes, scintillation fluid, et cetera). A further, less remote,
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possibility may have arisen from machine error/malfunction (especially the DNA plate
reader). However this is very unlikely because the results within each experiment were
fairly self-consistent.
4.6 Conclusions
This study seems to confirm the hypothesis that an extended alternate day
compression protocol can stimulate cartilage growth and repair in cartilage explants.
Increased levels of total GAG content and increased rates of extracellular matrix protein
synthesis were observed in the majority of experiments. Furthermore, the study also
seems to confirm the hypothesis that replacing FBS and L-ascorbic acid with ITS and
A2P, respectively did not significantly affect the results of free swell and dynamic
compression conditions. However, future research is needed to confirm the repeatability
of using the ITS-A2P feeding medium in the explant system.
4.7 Future Work
The first step in future work would be to repeat and validate the results of the later
experiments for free swell vs. dynamic compression and Regular vs. ITS-A2P media
conditions with larger N sizes for greater statistical confidence. It may also be interesting
to further vary the number of compression/rest days in the protocol to discover any
potential upper limits to the length of the explant viabilities. Further research would also
be needed to confirm these results for human cartilage systems. Before proceeding with
the study of the synergistic effects of IGF-I stimulation with the dynamic compression
protocol, it would be useful to investigate the variability issues of the assays seen during
the course of the experiments. Specifically, it would be useful to conduct a deeper study
on the DNA content assay because the DNA data is used to normalize the other assay
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results. Alternatively, other assays may be added to the protocol to observe other facets
of cartilage growth and repair. These assays might include measurement of wet and dry
weight or cell viability assays at various time points in the protocol.
Finally, experiments investigating the potential synergistic effects of IGF-I and
extended dynamic compression in the bovine explant system should be conducted and
studied to build on the data collected in this study. The data from that study should help
improve the understanding of the cellular mechanisms between the two stimulatory
pathways. For example, real-time polymerase chain reaction (PCR) assays may be
performed on the cartilage samples to probe into the gene expression activity of the
cartilage response to stimuli arising from two separate pathways. The results of that
study might be used to construct and/or extend existing mathematical models of the
mechanical and biochemical aspects of chondrocyte metabolism. The results of that
study might also lead to novel treatment therapies for osteoarthritis and other traumatic
knee injuries.
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Appendix A - GAG and DNA Content Assays
A.1 GAG Assay
A.1.1 Objectives
The goals of this experiment were to quantify the precision of the physical
pipeting processes of the GAG content assay and to quantify a useful range of GAG
standards for use in calculating actual GAG content from spectrophotometric GAG data.
A.1.2 Methods
Using a 2 mg/mL concentration of stock GAG solution, at least 200 tL of GAG
standards from 2 mg/mL down to 0 ug/mL were made by serial dilutions in Tris buffer.
Next, six other test GAG solutions were made, ranging between 15.38 and 66.67
ug/mL in concentration. Table Al shows the concentrations of the standards and test
solutions. Then using the previously described GAG content protocol, 2 sets of 20 PL of
each the GAG standards and test solutions were aliquoted into a 96 well microplate in
triplicate. For the first set, a new pipet tip was used for each of the three aliquots. For
the second set, the same pipet tip was reused for the three aliquots. Finally, the DMMB
dye was added as described previously and the photometric optical density (GD) results
were recorded, analyzed, and converted to pg/mL of GAG.
Table Al. GAG standards and test solutions.
GAG Standards [pig/mL]
2000.00 1000.00 500.00 200.00 100.00 50.00
25.00 12.50 6.25 3.13 1.56 0.00
GAG Test Solutions [pg/mL]
66.67 40.00 28.57 22.22 18.18 15.38
A.1.3 Results
Table A2 shows the OD results of the assay for the first set of aliquots (new tips).
The data in the first set indicates that the assay results saturate for concentrations above
100 pag/mL. The data also indicates that the standard deviation of each set of three
aliquots is usually within 3% of the mean of the set.
Table A3 shows the OD results of the assay for the second set of aliquots (reused
tips). The data in the second set again indicates that the assay results saturate for
concentrations above 100.00 ptg/mL. The data also indicates that the standard deviation
of each set of three aliquots is usually within 4% of the mean of the set, with the
exception of the 1000.00 tg/uL standard.
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Table A2. GAG Standards assay data for individual tips.
Standards Individual Tips Mean Std. Dev. Std. Dev/Mean
[ tg/mL] [OD] [OD] [OD] [%
2000.00 0.548 0.556 0.543 0.549 0.006557 1.19
1000.00 0.553 0.556 0.548 0.552 0.004041 0.73
500.00 0.547 0.565 0.537 0.550 0.014189 2.58
200.00 0.531 0.539 0.540 0.537 0.004933 0.92
100.00 0.493 0.487 0.486 0.489 0.003786 0.77
50.00 0.380 0.380 0.373 0.378 0.004041 1.07
25.00 0.295 0.297 0.290 0.294 0.003606 1.23
12.50 0.242 0.239 0.238 0.240 0.002082 0.87
6.25 0.214 0.210 0.211 0.212 0.002082 0.98
3.13 0.203 0.201 0.200 0.201 0.001528 0.76
1.56 0.192 0.188 0.191 0.190 0.002082 1.09
0.00 0.181 0.180 0.180 0.180 0.000577 0.32
Table A3. GAG Standards assay data for repeated tips.
Standards Repeated Tips Mean Std. Dev. Std. Dev/Mean
[ptg/mL-] [OD] [OD] [OD] [%
2000.00 0.543 0.546 0.555 0.548 0.006245 1.14
1000.00 0.548 0.543 0.454 0.515 0.052887 10.27
500.00 0.537 0.531 0.564 0.544 0.017578 3.23
200.00 0.540 0.521 0.541 0.534 0.011269 2.11
100.00 0.486 0.480 0.491 0.486 0.005508 1.13
50.00 0.373 0.372 0.378 0.374 0.003215 0.86
25.00 0.290 0.289 0.293 0.291 0.002082 0.72
12.50 0.238 0.238 0.239 0.238 0.000577 0.24
6.25 0.211 0.210 0.214 0.212 0.002082 0.98
3.13 0.200 0.197 0.200 0.199 0.001732 0.87
1.56 0.191 0.187 0.191 0.190 0.002309 1.22
0.00 0.180 0.182 0.185 0.182 0.002517 1.38
Figure Al shows three plots of the GAG standards between 0 and 50 (Trend 1), 0
and 100 (Trend 2), or 0 and 200 pg/mL (Trend 3), plots of the trendlines calculated for
each range of standards, and the corresponding equations for each trendline. The
trendlines were calculated as best fit linear curves using Microsoft EXCEL. Table A4
shows the concentrations of the GAG standards and test solutions calculated from each of
the three trendlines, as well as the error percentage.
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GAG Concentration vs. OD
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Figure Al. GAG standard data and fitted curves for various standard ranges.
Table A4. GAG standard curve fitting data for various standard ranges.
Standards Mean OD Trend 1 Trend 1 Trend 2 Trend 2 Trend 3 Trend 3
0 to 200 Error [% 0 to 100 Error [%] 0 to 50 Error [%]
2000.00 0.549 158.58 92.07 111.52 94.42 91.82 95.41
1000.00 0.552 160.12 83.99 112.57 88.74 92.67 90.73
500.00 0.550 158.89 68.22 111.73 77.65 91.99 81.60
200.00 0.537 152.87 23.57 107.65 46.18 88.70 55.65
100.00 0.489 130.63 30.63 92.57 7.43 76.53 23.47
50.00 0.378 79.20 58.41 57.70 15:39 4 8 .4 0  3.19
25.00 0.294 40.44 61.77 31.41 25.66 27.20 8.81
12.50 0.240 15.27 22.17 14.35 14.77 13.44 7.48
6.25 0.212 2.30 63-20 5.55 11.20 6.34 1.49
3.13 0.201 -2.49 179.59 2.30 3.72 19.1C
1.56 0.190 -7.58 585.34 -1.15 173.71 0.93 40.1c
0.00 0.180 -12.22 -4.29N/A -1.60
Tests Mean OD Trend 1 Trend 1 Trend 2 Trend 2 Trend 3 Trend 3
0 to 200 Error [%] 0 to 100 Error [%] 0 to 50 Error [%]
66.67
40.00
28.57
22.22
18.18
15.38
0.412
0.30£
0.303
0.280
0.263
0.252
95.26
47.39
44.46
33.80
26.24
21.14
42.90
18.48
55.60
52.11
44.30
37.41
68.59
36.13
34.14
26.91
21.78
18.32
2.88
9.68
19.48
21.10
19.79
19.11
57.19
31.00
29.40
23.57
19.43
16.65
14.22
22.4£
2.9C
6.07
6.88
8.1c
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A.1.4 Discussion and conclusions
The results in Tables A2 and A3 indicate that the OD results from a GAG assay
are sufficiently precise and repeatable. The standard deviation of a set of triplicate
sample aliquots typically falls within 3-4 percent of the mean of the set. Furthermore, the
results also indicate no appreciable increase in precision from changing tips between each
of the triplicate aliquots of a sample. Therefore, there should be negligible bias between
reusing tips (dry tip vs. "wet" tip) within a set of replicated aliquots, and pipet tips can be
reused for each GAG standard or test solution, saving a large number of tips.
Figure Al indicates that the trendline for a given range of GAG standards
becomes more accurate visually as the upper bound of the standard range decreases to 50
pg/mL. The results of Table A4 also indicate that a GAG standard of 50 pig/mL leads to
lower error values of calculated concentrations for both the standard and test solutions
that fall in the correct range. Table A4 also indicates a lower bound of 3.13 pg/mL (not
including the 0 tg/mL of pure Tris buffer) for the serially diluted GAG standards.
Therefore, the GAG standard range of 0 to 50 pg/mL leads to the best standard curve
while still providing a reasonably large data range.
A.2 DNA assay
A.2.1 Objectives
The goals of this experiment were to quantify the precision of the physical
pipeting processes of the DNA content assay and to quantify a useful range of DNA
standards for use in calculating actual DNA content from flurometric DNA data.
A.2.2 Methods
Using a 10 ptg/mL concentration of stock DNA solution, at least 200 p.L of DNA
standards from 10 jtg/mL down to 0 pg/mL were made by serial dilutions in Tris buffer.
Next, six other test DNA test solutions were made, ranging between 5.00 and 1.43
ug/mL in concentration. Table A5 shows the concentrations of the standards and test
solutions. Then using the previously described DNA content protocol, 2 sets of 20 piL of
each the DNA standards and test solutions were aliquoted into a 96 well microplate in
triplicate. For the first set, a new pipet tip was used for each of the three aliquots. For
the second set, the same pipet tip was reused for the three aliquots. Finally, the Hoechst
dye was added as described previously and the fluorometric count results were recorded,
analyzed, and converted to ug/mL of DNA.
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Table A5. DNA standards and test solutions.
DNA Standards [pg/mL]
10.00 8.00 6.00 5.00 2.50 1.25
0.63 0.31 0.16 0.08 0.04 0.00
DNA Test Solutions [pg/mL]
5.00 3.33 2.50 2.00 1.67 1.43
A.2.3 Results
Tables A6 and A7 show the results of the assay for the first set of aliquots (new
tips). The data in the first set indicate that the assay results do not saturate for
concentrations in question. However, the data indicate that the results become less
reliable if the concentration falls below 0.10 ptg/mL. The data also indicate that the
standard deviation of each set of three aliquots is usually within 7% of the mean of the
set.
Tables A8 and A9 show the results of the assay for the second set of aliquots
(reused tips). The data in the second set again indicate that the assay results do not
saturate for concentrations in question, and still indicate that the results become less
reliable if the concentration falls below 0.10 jag/mL. The data also indicate that the
standard deviation of each set of three aliquots is usually within 8% of the mean of the
set.
Table A6. DNA Standards assay data for individual tips.
Standards Individual Tips Mean Std. Dev. Std. Dev./Mean
[ tg/mL] [Counts] [Counts] [Counts] [%]
10.00 12931 12753 12498 12727.33 217.64 1.71
8.00 10283 10074 9855 10070.67 214.02 2.13
6.00 8365 7936 7670 7990.33 350.67 4.39
5.00 6793 6600 6811 6734.67 116.97 1.74
2.50 3905 3983 3673 3853.67 161.25 4.18
1.25 2334 2463 2196 2331.00 133.53 5.73
0.63 1629 1686 1715 1676.67 43.75 2.61
0.31 1207 1201 1223 1210.33 11.37 0.94
0.16 1032 1009 987 1009.33 22.50 2.23
0.08 903 951 1404 1086.00 276.44 25.45
0.04 928 1024 804 918.67 110.30 12.01
0.00 883 808 919 870.00 56.63 6.51
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Table A7. DNA test dilutions assay data for individual tips.
Test Dilutions Individual Tips Mean Std. Dev. Std. Dev./Mean
[pig/mL] [Counts] [Counts] [Counts] [%]
5.00 5935 6372 6117 6141.33 219.51 3.57
3.33 4795 4576 4552 4641.00 133.91 2.89
2.50 3920 3666 3722 3769.33 133.45 3.54
2.00 4506 4704 4618 4609.33 99.28 2.15
1.67 2604 2730 2697 2677.00 65.34 2.44
1.43 2544 2484 2523 2517.00 30.45 1.21
Table A8. DNA standards assay data for repeated tips.
Standards Repeated Tips Mean Std. Dev. Std. Dev./Mean
[pag/mL] [Counts] [Counts] [Counts] [%]
10.00 12498 12487 11972 12319.00 300.56 2.44
8.00 9855 9465 9593 9637.67 198.80 2.06
6.00 7670 7536 7270 7492.00 203.60 2.72
5.00 6811 6887 6854 6850.67 38.11 0.56
2.50 3673 3606 3631 3636.67 33.86 0.93
1.25 2196 2393 2341 2310.00 102.09 4.42
0.63 1715 1576 1535 1608.67 94.34 5.86
0.31 1223 1157 1094 1158.00 64.51 5.57
0.16 987 1129 961 1025.67 90.43 8.82
0.08 1404 894 792 1030.00 327.88 31.83
0.04 804 892 986 894.00 91.02 10.18
0.00 919 952 968 946.33 24.99 2.64
Table A9. DNA test dilutions assay data for repeated tips.
Test Dilutions Repeated Tips Mean Std. Dev. Std. Dev./Mean
[ptg/ml] [Counts] [Counts] [Counts] [%]
5.00 5935 6201 6257 6131.00 172.03 2.81
3.33 4795 4278 4445 4506.00 263.84 5.86
2.50 3920 3741 3580 3747.00 170.08 4.54
2.00 4506 4426 4756 4562.67 172.14 3.77
1.67 2604 2639 2721 2654.67 60.05 2.26
1.43 2544 2478 2450 2490.67 48.26 1.94
Figure A2 shows a plot of the DNA
visually corroborates the fact that the DNA
range of standards used.
standards between 0 and 10 ptg/mL. The plot
concentration does not saturate within the
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Figure A2. DNA standard curve.
Trendlines were calculated for two ranges of standards for 0.16 to 5.00 pg/rnL
(Trend 1) and 0 to 10.00 pg/mL (Trend 2), with concentrations < 0.10 omitted. Table
A10 shows the concentrations of the DNA standards and test solutions calculated from
Trend 1, as well as the error percentage. Table Al l shows the concentrations of the
DNA standards and test solutions calculated from Trend 1, as well as the error
percentage. The error percentages for both trends are similar and sufficiently low.
Table A10. DNA standard curve fitting data for Trend 1 (0.16 to 5.00 pg/mL).
DNA Standards Mean Trend 1 Error
[pg/mL] [Counts] [%]
10.00 12727.33 10.07 0.66
8.00 10070.67 7.81 2.37
6.00 7990.33 6.04 0.74
5.00 6734.67 4.98 0.43
2.50 3853.67 2.53 1.30
1.25 2331.00 1.24 0.83
0.6 167,6.67 -0.68 9.46
01.3 1210.33 :0.29 7.77
0.46 17009. 0.12 24.75
0.08 1086.00 0.18 133.82
0.04 918.67 0.04 3.96
0.00 870.00 0.00
DNA Test Dilutions Mean Trend 1 Error
[pg/ml-] [Counts] [%]
5.00 6141.33 4.47 10.51
3.33 4641.00 3.20 3.97
2.50 3769.33 2.46 1.57
2.00 4609.33 3.17 58.70
1.67 2677.00 1.53 7.99
1.43 2517.00 1.40 2.17
Table All. DNA standard curve fitting data for Trend 2 (0 an 0. 16 to 10.00 pig/mnL).
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DNA Standards Mean Trend 2
[pg/mL] [Counts]
8.00 10070.67
6.00 7990.33
Error
[%]
7.77
6.02
2.86
0.26
DNA Test Dilutions Mean Trend 2 Error
[pig/mL] [Counts] [%]
5.00 6141.33 4.46 10.9C
3.33 4641.00 3.19 4.33
2.50 3769.33 2.45 1.87
2.00 4609.33 3.16 58.11
1.67 2677.00 1.53 8.12
1.43 2517.00 1.40 2.26
A.2.4 Discussion and conclusions
The results in Tables A6, A7, A8, and A9 indicate that the results from a DNA
assay are sufficiently precise and repeatable. The standard deviation of a set of triplicate
sample aliquots typically falls within 8-10 percent of the mean of the set. While this
number is not as low as the value determined for the GAG assay, it should be sufficient
for the purposes of the assay. Also, the results show that DNA concentrations that fall
below 0.10 pg/mL become difficult to assay. Furthermore, the results also indicate no
appreciable increase in precision from changing tips between each of the triplicate
aliquots of a sample. Therefore, there should be negligible bias between reusing tips (dry
tip vs. "wet" tip) within a set of replicated aliquots, and pipet tips can be reused for each
DNA standard or test solution, saving a large number of tips.
Figure A2 indicates that the DNA concentration data does not saturate in the
range of 0 to 10 ptg/mL. The results of Tables J and K indicate that a DNA standard
range including 0 and 0.16 to 5.00 (or 10.00) pg/mL leads to an adequate standard curve
while still providing a reasonable data range.
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Appendix B - Experimental protocols
B.1 Cartilage explant and harvest
Materials
2 scalpel handles (sterile)
2 #10 scalpel blades
3 Tissue forceps (sterile)
2 Flat forceps (sterile)
Squirt bottle (sterile)
3 mm dermal punch (sterile)
Metal spatula (sterile)
Knife or Hacksaw
9 mm hollow drill bit
12 well culture plate(s)
24 or 48 well culture plate(s)
Sterile PBS with PenStrep
Feeding Medium
Coring
1. Using a scalpel, cut away enough muscle on the proximal end of the femur of the calf
joint to be able to mount the joint to the drilling apparatus (Figure B 1).
2. Expose the femoropatellar groove by carefully cutting open the join capsule and
severing the medial, lateral, and cruciate ligaments.
3. Remove the tibia, patella, and surrounding tissues with scalpel and forceps.
4. Constantly wash down the articular cartilage with the sterile PBS supplemented with
PenStrep in squirt bottle.
5. Adjust the drilling apparatus to place a roughly horizontal surface of the groove under
the drill press.
6. Using a 9mm hollow drill bit, penetrate at least 2 mm into the groove to obtain a core.
Up to 5 cores from the medial side and up to 4 cores from the lateral side can be
harvested. Wash down the cores with the PBS solution throughout the coring process.
7. After drilling, use a knife or hacksaw to cut through the side of the joint to release the
cores. The cores must be long enough to have sufficient bone to mount into the
microtome.
8. Place cores in a 12 well culture plate and cover with PBS solution.
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Figure B1. Drilling apparatus.
Slicing
1. Place a core into the polysulfone holder for the microtome (Figure B2).
2. Rotate the microtome height dial counterclockwise until the blade is well above
theheight of the mounted core.
3. Rotate the dial clockwise to successive 6 o'clock positions (bottom) until the most
superficial layer of the core can be removed to leave a flat surface (Figure B3).
Remove the uneven layer.
4. For the first 1 mm slice, rotate the dial clockwise to roughly the second instance of
the 5 o'clock position (690 degrees clockwise form previous position) (Figure B3).
5. Place a sterile petri dish in front of the microtome to catch potentially falling slices,
and slice with the blade.
6. Holding the slice with forceps, measure the slice thickness with the digital caliper and
place in a labeled culture dish well with enough PBS solution to cover.
7. For the second 1 mm slice, rotate the dial clockwise to roughly the second instance of
the 4 o'clock position (690 degrees clockwise from previous position) (Figure B3).
The exact position may need to be adjusted by experience if the previous slice was
too thin/thick.
8. Slice, measure, and store the slice as before.
9. Repeat for the remainder of the cores.
Figure B2. Polysulfone holder and microtome.
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Figure B3. Dial at successive slice positions: uneven superficial slice (6 o'clock), first 1 mm slice (5
o'clock), and second 1 mm slice (4 o'clock).
Punching
1. Under the hood, transfer a slice using forceps and spatula into a sterile petri dish with
enough of the PBS solution to cover.
2. Using a sterile 3 mm dermal punch, take four plugs from each slice.
3. Transfer the plugs into labeled wells of a culture plate.
4. Aliquot 0.5 mL of feeding medium into each well.
5. Incubate ~48 hours to allow plugs to reach metabolic steady state before beginning
experiments. Change the feeding media every 2 days if necessary.
B.2 Mechanical loading (dynamic compression)
Sample preparation
1. Under the hood, transfer and center the plugs into the wells of the polysulfone loading
chamber (Delta series) (Figure B4).
2. Gently aliquot 0.5 mL of the appropriate feeding medium into each well so as not to
move the plugs within the wells.
3. Align the chamber cover to the chamber bottom and carefully put in place.
4. Transfer the chamber from the hood into the custom build compression apparatus
(Figure B4) in the incubator.
Figure B4. Polysulfone load chamber (Delta series) and custom built compression apparatus.
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Compression protocol
1. Click the Dynamic Acquisition Software icon to start the compression program.
2. In the "File" drop down menu on the main screen click on "Change User" (Figure
B5).
3. Select the folder where data will be saved and click <OK> to return to the main
screen (Figure B5).
4. In the "Control" drop down menu and click on the "Axial Position" tab (Figure B6).
5. Click on the "Load" text field and enter "-50 g" (Figure B6).
6. Click on the <Update> button to calibrate the chamber in the compression apparatus
(the platen should just make contact with the top of the chamber). Click <OK> to
return to the main screen (Figure B6).
7. In the "File" drop down menu on the main screen click on "Select Protocol". Choose
the appropriate protocol for the experiment. The protocol should be displayed in the
main screen (Figure B6).
8. The sample protocol in Figure B6 was used for the loading protocol.
Figure B5. Compression protocol step #2 through #3 screenshot.
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Figure B6. Compression protocol steps #4 through #8 screenshot.
B.3 GAG content assay
Materials
Stock GAG standard solution (2 mg/mL)
Tris buffer
DMMB Dye
96 well microplate (Clear Bacti Plate, NUNC, #269620)
GAG standards reparation
Tube
1 2
Standard [ptg/mL]
(Stock GAG solution diluted lOx)
2 100
3 50
4 25
5 12.5
6 6.25
7 3.125
8 0 (Tris Buffer)
1. Thaw at least 100 pL of frozen stock GAG solution (2 mg/mL) at room temperature.
2. Prepare the Tris buffer solution.
3. Label 7 test tubes #1-8 for the serial dilution.
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0
4. Add 900 pL of Tris buffer to tube #1.
5. Add 100 ptL of Tris buffer to tube #2-8.
6. Add 100 piL of GAG stock solution to tube #1.
7. Vortex tube #1 and take a 100 pL aliquot to tube #2.
8. Vortex tube #2 and take a 100 ptL aliquot to tube #3.
9. Continue serial dilution through tube #7. Save tube #8 with just Tris buffer.
Sample preparation
1. Check that there is enough DMMB dye and that it is not expired.
2. For each digested cartilage plug sample, add 100 piL of sample solution and 900 piL
of Tris buffer into test tube and vortex for a 1 Ox dilution.
3. Aliquot 20 piL of GAG standards in triplicate into the 96 well microplate
4. Aliquot 20 ptL of GAG test samples in triplicate into the 96 well microplate.
5. Using a multichannel pipet, aliquot 200 tL of DMMB dye into each well.
6. Gently tap microplate to remove any air bubbles.
Using MAXY microplate reader/software (Vmax, Molecular Devices)
Figure B7. MAXY.
1. Power on MAXY and adjust the wavelength to 520 nm (on left side of machine).
2. Click on the MAXY icon to start the software.
3. Adjust wavelength to 520 nm in MAXY software (Figure B8).
4. Adjust options:
a. Click the "Shake (AUTOMIX)" option is OFF. This option should only be
used if the plate is specially sealed for mixing.
b. Click the "Calibrate before reading" option ON.
c. Click the "Eject plate after reading" option ON.
5. Read a blank plate to verify correct operation of machine by clicking <Read Plate>.
6. Open data file for saving data by clicking on folder icon in the upper left corner.
7. Read the microplate at 520 nm by clicking <Read Plate>.
8. Record data.
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Figure B8. MAXY software main screen, steps #3 through #7.
B.4 DNA content assay
Materials
Stock DNA standard solution (10 pg/mL)
Tris buffer
TEN Buffer
Hoechst Dye
96 well microplate (Microfluor 2 Black, ThermoLab Systems, #7805)
DNA standards preparation
Tube
1 10
Standard [pg/mL]
(Stock DNA solution)
2 5
3 2.5
4 1.25
5 0.625
6 0.312
7 0.156
8 0 (Tris Buffer)
1. Thaw at least 100 iL of frozen stock DNA solution (10 pg/mL) at room temperature.
2. Prepare the Tris buffer solution.
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3. Label 7 test tubes #1-8 for the serial dilution.
4. Add 100 ptL of Tris buffer to tube #1-8.
5. Add 100 pL of DNA stock solution to tube #1.
6. Vortex tube #1 and take a 100 tL aliquot to tube #2.
7. Vortex tube #2 and take a 100 iL aliquot to tube #3.
8. Continue serial dilution through tube #7. Save tube #8 with just Tris buffer.
Sample preparation
1. Check that there is enough Hoechst dye and that it is not expired.
2. Dilute Hoechst dye 10,000x in TEN buffer (5 tL Hoechst dye in 50 mL TEN buffer.
3. Aliquot 20 p.L of DNA standards in triplicate into the 96 well microplate
4. Aliquot 20 iL of DNA test samples in triplicate into the 96 well microplate.
5. Using a multichannel pipet, aliquot 200 iL of Hoechst dye into each well.
6. Gently tap microplate to remove any air bubbles.
Using Victor Microplate Reader (Wallac 1420 Multilabel Counter, ThermoLab Systems)
Figure B9. Victor.
1. Restart computer, and power on Victor (switch above power plug at rear of machine).
2. Click on the Victor icon to start the software and wait for initialization.
3. In the main screen, click the second button in the row of icons/buttons under the drop
down menus to start the new assay wizard (Figure B 10).
4. In the wizard screen, select the appropriate protocol and click <Next> (Figure B 11).
5. Specify wells for measurement (Dark blue = measure, Clear = no measure) and click
<Next> (Figure B12).
6. Add any notes or information and click <Next> (Figure B 13).
7. Insert microplate into Victor and click <Next> to begin assay (Figure B 14).
8. In the main screen, click the "Live display" tab to observe assay (Figure B 15).
9. Upon the conclusion of the protocol, click on the third button in the row of
icons/buttons under the drop down menus to bring up the data. Export the data from
the File menu of the data.
Notes
1. The "DNA-Quant" protocol was used for these experiments.
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ware screenshot, step #3.
Figure B11. Victor software screenshot, step #4.
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Figure B12. Victor software screenshot, step #5.
Figure B13. Victor software screenshot, step #6.
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Figure B14. Victor software screenshot, step #7.
iigure BIS. Victor software screenshot, step #8.
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B.5 Radiolabel incorporation
Materials
Media to be labeled.
20 mL and 200 mL pipetman
Sterile pipette tips.
Aluminum foil
Latex gloves
Radionuclides
Sterile spatulas
Cold PBS with 0.8 mM Na2SO 4 and 1.0 mM proline
Preparation of radioactive media
1. Calculate volume of isotope needed:
3 5
s Vol total volume 35S label needed
3H Voltotal volume 3H label needed
V total volume media needed [mL]
A radioactive activity L i
mL
Cs = sulfate concentration
mL_
CH sulfate concentration
_ mL_
T = time past calibration date [day]
For 35S, the half-life is 87.4 days:
A = 10,000 -2-/7.4 pCi]
ImL_
35 Vol = [mL]
For 3H, the half-life is 8-9 years so the activity remains 1000 [tCi/mL]:
3 HFV = HmL1000
2. Wipe hood with 70% EtOH and line work area with aluminum foil.
3. Double glove and tape lab coat sleeves.
4. Carefully place radionuclides in hood on foil and loosen caps.
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5. Aliquot calculated volume of 35S radionuclide using sterile technique into medium to
be labeled. Return pipette tip to paper wrapper.
6. Save 1 mL media for calibration. Return pipette tip to paper wrapper.
7. Aliquot calculated volume of 3H radionuclide using sterile technique into medium to
be labeled. Return pipette tip to paper wrapper.
8. Save 1 mL media for calibration. Return pipette tip to paper wrapper.
6. Return radionuclides into containers, return to storage, and note amounts used in
logbook.
7. Dispose of all material used in cleaning hood and preparing media into radioactive
waste containers.
Labeling
1. Wipe hood with 70% EtOH and line work area with aluminum foil.
2. Aspirate plug media from wells in culture plate.
3. Aliquot 0.5 mL radiolabeled media per well using sterile technique. Return pipet tip
to paper wrapper.
4. Return plugs to incubator for desired radiolabel time.
5. Dispose of all material used in aliquoting media into radioactive waste containers.
Washing
1. Complete PBS solution with 0.8 mM Na2 SO 4 and 1.0 mM proline.
2. Wipe hood with 70% EtOH and line work area with aluminum foil.
3. Remove radioactive media with a pipette and aliquot into a waste container.
4. Aliquot 1 mL of PBS per well and refrigerate for 15 minutes.
5. Repeat media removal, wash, and refrigeration 3x for a total of 4 washes of 15
minutes each.
6. Place each sample in a vial. Samples are now ready for proteinase K digestion.
7. Dispose of radioactive media in sink and note amount of radioactivity disposed.
8. Dispose of all materials used in aliquoting media into radioactive waste containers.
B.6 Liquid scintillation counting
Standard and sample preparation
1. Aliquot 20 ptL of radiolabel standards ([media + 35S] and [media + 3H and 35 S]) in
duplicate into scintillation vials.
2. Aliquot 100 piL of radiolabeled cartilage samples in duplicate into scintillation vials.
3. Dispense 2 mL of scintillation fluid into each vial.
4. Cap vial, close tightly, and vortex to mix well.
5. Label top of vials (NOT the sides) with sample numbers.
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Using the Liquid scintillation counter (RackBeta 1211, LKB)
6. RackBeta liquid scintillation counter.
1. Power on the counter.
2. Click on the LSC icon to start the software.
3. Enter ID into the "User" pull down field. If an email address is entered (e.g.
garylee@mit.edu), the program will output an email when the job is finished (Figure
B 17).
4. Screen for radioactive contamination:
a. Place the LSC racks (with empty glass vials) into the loading area of the
counter. Place a "stop" rack (a rack with no glass vials) as the last rack.
b. Select "3H, 35S" from the "Isoptope" pull down field.
c. Select "0:30" (30 seconds) from the "Time" pull down field.
d. Select "1" from the "Repeats" pull down field.
e. Click the "Chemiluminescence" option OFF. This option adds
chemiluminscence (CLM) and percent error to the output, listed as CPM5 and
CLM%, respectively. The CPM5 count is the total count out of the
photomultiplier tubes, while CLM% is interpreted as the fraction of channel 1
counts due to the CPM5 counts.
f. Click the "Percent Error" option ON. This option adds the channel 1 and
channel 2 percent errors to the output. This is always printed if only one or
two channels are specified by the isotope.
g. Click the "Ratio" option ON. This option adds the ration of channel 4 to
channel 3 counts to the output. The CPM3 and CPM4 channels are
automatically set to the CPM 1 and CPM2 windows if two channels are
specified by the isotope.
h. Click the "High Count Reject" option OFF. This option lists samples with
counts greater than 3 million cpm as "HCR" in the output. By default, this
option is off, but counts greater than 3 million cpm may not be linear.
i. Click on the <Add to Queue> button. This will prompt for an output file,
which can be a new or existing file to which to append data.
j. When the job is finished, open the data file and check for radioactively
contaminated vials. Replace any contaminated glass vials and save them for
cleaning.
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5. Place the scintillation vials into the glass tubes in the liquid scintillation counter racks
(up to 10 per rack). Place a "stop" rack as the last rack as before.
6. Start the LSC:
a. Select "3H, 35S" from the "Isoptope" pull down field.
b. Select "3:00" (3 minutes) from the "Time" pull down field.
c. Select "1" from the "Repeats" pull down field.
d. Click the other options as before.
e. Click on the <Add to Queue> button and input the output file name as before.
7. Record the results upon the completion of the LSC.
Figure B17. Scintillation counter software screenshot, steps #3 through #7.
B.7 Solutions
Regular Feeding Medium
For 50 mL:
45 mL DMEM (high glucose)
5 mL fetal bovine serum (FBS)
500 pL 1M HEPES buffer
500 pL non-essential amino acid solution
500 p.L sodium pyruvate solution
500 ptL PenStrep
200 pL stock proline
200 ptL L-ascorbic acid
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ITS Feeding Medium
For 50 mL:
49 mL DMEM (high glucose)
500 pxL ITS
500 tL IM HEPES buffer
500 tL non-essential amino acid solution
500 pL sodium pyruvate solution
500 ptL PenStrep
200 tL stock proline
200 iL L-ascorbic acid
A2P Feeding Medium
For 50 mL:
45 mL DMEM (high glucose)
5 mL fetal bovine serum (FBS)
500 ptL 1M HEPES buffer
500 iL non-essential amino acid solution
500 tL sodium pyruvate solution
500 ptL PenStrep
200 pL stock proline
200 tL ascorbyl-2-phosphate (A2P)
ITS-A2P Feeding Medium
For 50 mL:
49 mL DMEM (high glucose)
500 tL ITS
500 pL IM HEPES buffer
500 pL non-essential amino acid solution
500 pL sodium pyruvate solution
500 pL PenStrep
200 pL stock proline
200 pL ascorbyl-2-phosphate
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Appendix C - Experimental Results and Details
Experiment 1
Table Cl. Experiment 1: Cartilage harvest data.
Plug
Slice A B C D
1 Control DC N/A N/A
2 Control DC N/A N/A
3 Control DC N/A N/A
4 Control DC N/A N/A
5 Control DC N/A N/A
6 Control DC N/A N/A
Table C2. Experiment 1: Individual cartilage plug assay data.
Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc.
Control 1 25.95 1.62 209.43
Control 2 20.51 1.83 169.09
Control 3 17.94 1.22 201.08
Control 4 16.36 1.26 186.78
Control 5 22.58 2.02 144.66
Control 6 13.11 0.97 250.49
Dynamic 1 19.21 1.57 180.12
Dynamic 2 21.26 1.39 191.77
Dynamic 3 22.94 2.65 124.69
Dynamic 4 20.15 1.37 199.18
Dynamic 5 19.18 1.26 175.92
Dynamic 6 12.99 1.24 188.72
Table C3. Experiment 1: Radiolabel protocol parameters.
Media Total 35S Activity 3H Activity Total 35S Total 355
Volume Concentration Concentration Volume Volume
[mL] [p0Ci/mL] [pCi/mL] [pl] [LRegular 18.001 10.001 20.001 23.801 340 .00
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Table C4. Experiment 1: 24 hour sulfate incorporation ANOVA analysis.
Experiment 1 - 24 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 8.925668 1.487611 0.162167 0.164402
DC 6 9.483358 1.58056 0.290397 0.219999
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 0.025918 1 0.025918 0.114539 0.742033 4.964591
Within Groups 2.262821 10 0.226282
Total 2.288739 11
Table C5. Experiment 1: 24 hour proline incorporation ANOVA analysis.
Experiment 1 - 24 Hr Proline
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 116.4459 19.40766 21.03784 1.872513
DC 6 115.7345 19.28908 11.52634 1.386022
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 0.042183 1 0.042183 0.002591 0.960408 4.964591
ithin Groups 162.8209 10 16.28209
Total 162.8631 11
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Table C6. Experiment 1: 24 hour GAG ANOVA analysis.
Experiment 1 - 24 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 1161.544 193.5907 1317.014 14.81561
DC 6 1060.397 176.7328 718.919 10.94622
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 852.5665 1 852.5665 0.837519 0.381645 4.964591
Within Groups 10179.67 10 1017.967
Total 11032.23 11
Experiment 2
Table C7. Experiment 2: Cartilage harvest data.
Plug
Slice A B C D
1 Control A DC A Control B DC B
2 Control A DC A Control B DC B
3 Control A DC A Control B DC B
Control A DC A Control B DC B
5 Control A DC A Control B DC B
6 Control C DC C N/A N/A
7 Control C DC C N/A N/A
8 Control C DC C N/A N/A
9 Control C DC C N/A N/A
Table C8. Experiment 2: Individual cartilage plug assay data.
ISample pmol Proline/ pmol Sulfate/ Normalized
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(ug DNA / hr) (ug DNA / hr) GAG Conc.
Control A_1 0.53 17.95 38.07
Control A_2 0.40 13.91 45.20
Control A_3 0.40 13.71 43.41
Control A_4 0.16 14.82 48.19
Control A 5 1.09 26.09 53.80
DC A_1 2.90 69.24 82.80
DC A_2 1.35 31.90 41.99
DC A_3 1.47 46.81 42.31
DC A_4 1.41 29.52 52.41
DC A 5 0.71 31.54 50.82
Control B_1 0.60 22.84 37.06
Control B_2 -0.34 47.57 110.65
Control B_3 0.18 12.16 30.75
Control B_4 0.14 21.99 38.32
Control B 5 0.43 21.52 53.10
DC B_1 0.81 22.64 29.21
DC B_2 0.09 24.49 38.12
DC B_3 0.45 32.56 43.48
DC B_4 1.28 23.48 44.84
DCB 5 2.24 45.99 47.11
Control C_1 0.76 24.68 37.44
Control C_2 0.25 17.94 33.12
Control C_3 0.21 8.14 33.46
Control C 4 0.48 30.31 147.62
DC C_1 1.25 30.75 38.70
DC C_2 0.20 36.23 38.5c
DC C_3 0.35 26.09 44.41
DC C_4 1.11 22.32 51.07
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Table C9. Experiment 2: Radiolabel protocol parameters.
Media Total 35S Activity 3H Activity Total 35 S Total 35S
Volume Concentration Concentration Volume Volume
[mL] [p.Ci/mL] [ptCi/mL] [pL] [pLl
Regular 23.00 10.00 20.00 35.60 440.00
Table C10. Experiment 2: 24 hour sulfate incorporation ANOVA analysis.
Experiment 2 - Sulfate 24 Hr
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 14 293.6228 20.97306 95.42516 2.610763
DC 14 473.5821 33.82729 163.5943 3.418378
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 1156.62 1 1156.62 8.930754 0.006053 4.2252
ithin Groups 3367.253 26 129.5097
Total 4523.873 27
Table C11. Experiment 2: 24 hour GAG ANOVA analysis.
Experiment 2 - 24 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 14 750.1786 53.58419 1127.273 8.973265
DC 14 645.8728 46.13377 149.0482 3.262867
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 388.5612 1 388.5612 0.608877 0.442257 4.2252
ithin Groups 16592.17 26 638.1605
Total 16980.73 27
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Experiment 3
Table C12. Experiment 3: Cartilage harvest data.
Plug
Slice A B C D
1 Control 1 Control 1 DC 1 DC 1
2 Control 1 Contorl 1 DC 1 DC 1
3 Control 2 Control 2 DC 2 DC 2
4 Control 2 Control 2 DC 2 DC 2
5 Control 3 Control 3 DC 3 DC 3
6 Control 3 Control 3 DC 3 DC 3
Table C13. Experiment 3: Individual cartilage plug assay data.
Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc.
Con 1_1 N/A 80.05 38.86
Con 1_2 N/A 41.06 21.82
Con 1_3 N/A 110.26 76.00
Con 1 4 N/A 39.90 35.56
DC 1_1 N/A 106.78 63.28
DC 1_2 N/A 103.78 73.22
DC 1_3 N/A 0.00 0.00
DC 1 4 N/A 131.85 251.57
Con 2_1 N/A 121.37 0.00
Con 2_2 N/A 97.65 35.82
Con 2_3 N/A 190.82 50.32
Con 2 4 N/A 254.71 71.89
DC 2_1 N/A 219.87 49.43
DC 2_2 N/A 196.11 42.28
DC 2_3 N/A 158.98 37.63
DC2 4 N/A 137.90 48.55
Con 4_1 N/A 78.39 48.31
Con 4_2 N/A 43.44 43.16
Con 4_3 N/A 73.62 35.23
Con 4 4 N/A 83.20 55.79
DC 4_1 N/A 106.08 56.39
DC 4_2 N/A 168.50 136.12
DC 4_3 N/A 384.79 234.56
DC 4 4 N/A 207.79 114.95
Table C14. Experiment 3: Radiolabel protocol parameters.
Media Total 35S Activity 3H Activity Total 3s Total 35S
Volume Concentration Concentration Volume Volume
[mL] [ Ci/mL] [pCi/ml0] [.L] [0L]
Regular, 15.001 10.001 20.001 12.801 280.00
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Table C15. Experiment 3: 1 hour sulfate incorporation ANOVA analysis.
Experiment 3 - 1 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 4 271.2697 67.81744 1148.628 16.94571
DC 3 342.4022 114.1341 237.585 8.899156
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 3677.539 1 3677.539 4.689477 0.082609 6.607877
Within Groups 3921.055 5 784.211
Total 7598.594 6
Table C16. Experiment 3: 1 hour GAG ANOVA analysis.
Experiment 3 - 1 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 4 172.2415 43.06038 536.7972 11.58444
DC 3 388.0739 129.358 11226.28 61.17266
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 12766.75 1 12766.75 2.652781 0.164298 6.607877
Within Groups 24062.96 5 4812.591
Total 36829.71 6
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Table C17. Experiment 3: 2 hour sulfate incorporation ANOVA analysis.
Experiment 3 - 2 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 4 664.5434 166.1359 5050.053 35.53186
DC 4 712.8621 178.2155 1350.342 18.3735
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 291.8364 1 291.8364 0.091193 0.772859 5.987374
ithin Groups 19201.18 6 3200.197
Total 19493.02 7
Table C18. Experiment 3: 2 hour GAG ANOVA analysis.
Experiment 3 - 2 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 3 158.0265 52.67548 329.5437 10.48083
DC 4 177.8857 44.47143 30.93761 2.781079
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 115.3826 1 115.3826 0.767273 0.421143 6.607877
ithin Groups 751.9001 5 150.38
Total 867.2827 6
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Table C19. Experiment 3: 4 hour sulfate incorporation ANOVA analysis.
Experiment 3 - 4 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 4 278.6422 69.66055 320.9262 8.957207
DC 4 867.1547 216.7887 14298.48 59.78812
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 43293.37 1 43293.37 5.922728 0.050908 5.987374
Within Groups 43858.21 6 7309.701
Total 87151.58 7
Table C20. Experiment 3: 4 hour GAG ANOVA analysis.
Experiment 3 - 4 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 4 182.4875 45.62188 74.87655 4.326562
DC 4 542.0219 135.5055 5498.111 37.07462
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 16158.12 1 16158.12 5.798727 0.052713 5.987374
ithin Groups 16718.96 6 2786.494
Total 32877.08 7
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Experiment 4
Table C21. Experiment 4 cartilage harvest data.
Plug
Slice A B C D
1 Control 1 DC 1 DC 1 Lost
2 Control 1 DC 1 DC 1 DC 1
3 Control 2 DC 2 DC 2 DC 2
4 Control 2 DC 2 Lost DC 2
Table C22. Experiment 4 individual cartilage plug assay data.
Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc.
Con 1_1 3.59 29.08 88.34
Con 1_2 2.33 11.72 163.50
DC 1_1 3.42 27.96 102.93
DC 1_2 3.16 31.09 118.02
DC 1_4 5.63 22.50 238.37
DC 1_5 2.90 25.35 125.62
DC 1 6 2.23 20.64 173.37
Con 2_1 1.08 13.19 122.91
Con 2 2 1.66 23.23 157.50
DC 2_1 2.26 41.81 180.27
DC 2_2 1.61 20.78 163.27
DC 2_3 1.69 45.91 203.44
DC 2_4 1.04 24.50 139.24
DC 2 6 1.71 23.83 141.17
Table C23. Experiment 4 radiolabel protocol parameters.
Media Total 35s Activity 3H Activity Total 3S Total 3S
Volume Concentration Concentration Volume Volume
[mL] [Ci/mL] [p0Ci/mL] [pL] 4[pL]
Regular 10.001 20.001 40.001 18.001 360.001
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Table C24. Experiment 4: 1 hour sulfate incorporation ANOVA analysis.
Experiment 4 - 1 Hr - Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 2 40.79672 20.39836 150.7553 8.682029
DC 5 127.5395 25.5079 17.47246 1.869356
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 37.29627 1 37.29627 0.845164 0.400102 6.607877
ithin Groups 220.6451 5 44.12902
Total 257.9414 6
Table C25. Experiment 4: 1 hour proline incorporation ANOVA analysis.
Experiment 4 - 1 Hr - Proline
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 2 5.918368 2.959184 0.801653 0.633108
DC 5 17.35273 3.470545 1.656131 0.575523
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 0.373558 1 0.373558 0.251514 0.637308 6.607877
Within Groups 7.426178 5 1.485236
Total 7.799736 6
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Table C26. Experiment 4: 1 hour GAG ANOVA analysis.
Experiment 4 - 1 Hr - GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 2 251.8405 125.9203 2824.814 37.58201
DC 5 758.3071 151.6614 3043.362 24.67129
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 946.5818 1 946.5818 0.315564 0.598532 6.607877
ithin Groups 14998.26 5 2999.653
Total 15944.85 6
Table C27. Experiment 4: 2 hour sulfate incorporation ANOVA analysis.
Experiment 4 - 2 Hr - Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 2 36.41205 18.20602 50.39163 5.019543
DC 5 156.8242 31.36484 134.0912 5.178633
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 247.3636 1 247.3636 2.10789 0.206257 6.607877
ithin Groups 586.7565 5 117.3513
Total 834.1201 6
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Table C28. Experiment 4: 2 hour proline incorporation ANOVA analysis.
Experiment 4 - 2 Hr - Proline
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 2 2.742411 1.371205 0.168247 0.290041
DC 5 8.315184 1.663037 0.188173 0.193997
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 0.121665 1 0.121665 0.660549 0.453311 6.607877
ithin Groups 0.92094 5 0.184188
Total 1.042605 6
Table C29. Experiment 4: 2 hour GAG ANOVA analysis.
Experiment 4 - 2 Hr - GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 2 280.4139 140.2069 598.0776 17.29274
DC 5 827.3832 165.4766 736.107 12.13348
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 912.2259 1 912.2259 1.287543 0.307952 6.607877
ithin Groups 3542.506 5 708.5011
Total 4454.731 6
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Experiment 5
Table C30. Experiment 5 cartilage harvest data.
Plug Thickness
Slice A B C D [mm]
1 Control 1 DC 1 Control 2 DC 2 0.98
2 Control 1 DC 1 Control 2 DC 2 0.97
3 Control 1 DC 1 Control 2 DC 2 0.99
4 Control 1 DC 1 Control 2 DC 2 0.98
5 Control 1 DC 1 Control 2 DC 2 0.99
6 Control 1 DC 1 Control 2 DC 2 1.00
7 Control 4 DC 4 Control 24 DC 24 1.00
8 Control 4 Lost Control 24 DC 24 1.04
9 Control 4 DC 4 Control 24 DC 24 1.05
10 Control 4 DC 4 Control 24 DC 24 1.00
11 Control 4 DC 4 Control 24 DC 24 1.02
12 Control 4 DC 4 Control 24 DC 24 1.03
Table C31. Experiment 5 individual cartilage plug assay data.
Sample pmol Proline/ pmol Sulfate/ Normalized Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc. (ug DNA / hr) (ug DNA / hr) GAG Conc.
Control 1_1 229.50 168.13 150.02 Control 4_1 1319.00 1029.98 933.01
Control 1_2 188.29 143.09 108.11 Control 4_2 2206.55 1579.09 1457.32
Control 1_3 229.94 126.89 146.62 Control 4_3 457.54 413.59 321.12
Control 1_4 231.67 174.10 177.62 Control 4_4 839.28 811.08 507.90
Control 1_5 183.65 131.87 154.97 Control 4_5 599.22 680.29 422.62
Control 1 6 239.30 192.03 157.73Control 4 6 629.50 553.69 331.03
DC 1_1 409.57 215.88 196.63 DC 4_1 159.32 124.61 106.18
DC 1_2 342.66 184.20 169.26 DC 4_2 N/A N/A N/A
DC 1_3 333.62 180.18 147.20 DC 4_3 575.99 554.14 501.13
DC 1_4 304.41 163.98 184.57 DC 4_4 695.57 545.98 457.43
DC 1_5 245.29 157.58 149.39 DC 4_5 94.10 113.87 124.68
DC 1 6 276.09 201.83 176.93 DC 4 6 508.38 427.23 309.74
Control 2_1 111.80 42.32 181.52 Control 24_1 194.54 207.58 160.96
Control 2_2 73.27 23.76 138.08Control 24_2 133.29 107.00 112.00
Control 2_3 174.75 60.96 189.76Control 24_3 107.28 152.41 122.09
Control 2_4 125.32 45.52 183.65Control 24_4 125.60 141.97 115.80
Control 2_5 77.10 26.51 146.67 Control 24_5 114.06 223.75 154.09
Control 2 6 96.09 39.13 163.59Control 24 6 145.12 171.75 145.16
DC 2_1 134.87 33.69 175.09 DC 24_1 187.92 221.17 175.60
DC 2_2 132.95 37.52 139.46 DC 24_2 140.83 192.88 150.97
DC 2_3 158.24 49.64 158.59 DC 24_3 99.75 187.80 182.18
DC 2_4 165.62 60.24 186.53 DC 24_4 104.14 197.62 182.85
DC 2_5 125.08 35.28 65.61 DC 24_5 61.18 151.22 163.33
DC 2 6 128.74 43.24 159.57 DC 24 6 142.61 254.25 138.25
100
Table C32. Experiment 5 radiolabel protocol parameters.
Media Total 35S Activity 3H Activity Total 35S Total 35S
Volume Concentration Concentration Volume Volume
[mL] [pCi/mL] [pCi/mL] [pL] [pL]
Regular 27.00 20.00 40.00 63.80 1040.00
Table C33. Experiment 5: 1 hour sulfate incorporation ANOVA analysis.
Experiment 5 - 1 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 936.1192 156.0199 673.9036 10.59798
DC 6 1103.652 183.942 489.4754 9.032123
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 2338.929 1 2338.929 4.020924 0.072752 4.964591
ithin Groups 5816.895 10 581.6895
Total 8155.825 11
Table C34. Experiment 5: 1 hour proline incorporation ANOVA analysis.
Experiment 5 - 1 Hr Proline
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 1302.347 217.0578 594.5216 9.954242
DC 6 1911.633 318.6056 3292.338 23.42484
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 30935.83 1 30935.83 15.91816 0.00256 4.964591
ithin Groups 19434.3 10 1943.43
Total 50370.13 11
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Table C35. Experiment 5: 1 hour GAG ANOVA analysis.
Experiment 5 - 1 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 895.0659 149.1777 521.919 9.326655
DC 6 1023.98 170.6633 382.3845 7.983154
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 1384.898 1 1384.898 3.062906 0.11066 4.964591
Within Groups 4521.517 10 452.1517
Total 5906.415 11
Table C36. Experiment 5: 2 hour sulfate incorporation ANOVA analysis.
Experiment 5 - 2 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 238.2125 39.70208 184.1828 5.540499
DC 6 259.6129 43.26882 103.4542 4.152393
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 38.16493 1 38.16493 0.265369 0.61765 4.964591
ithin Groups 1438.185 10 143.8185
Total 1476.35 11
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Table C37. Experiment 5: 2 hour proline incorporation ANOVA analysis.
Experiment 5 - 2 Hr Proline
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 658.3257 109.7209 1411.155 15.33599
DC 6 845.4917 140.9153 281.9 6.854439
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 2919.261 1 2919.261 3.448512 0.092969 4.964591
ithin Groups 8465.276 10 846.5276
Total 11384.54 11
Table C38. Experiment 5: 2 hour GAG ANOVA analysis.
Experiment 5 - 2 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 1003.273 167.2121 453.4164 8.693066
DC 6 884.8452 147.4742 1864.83 17.62966
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 1168.757 1 1168.757 1.008312 0.338986 4.964591
Within Groups 11591.23 10 1159.123
Total 12759.99 11
103
Table C39. Experiment 5: 24 hour sulfate incorporation ANOVA analysis.
Experiment 5 - 24 Hr Sulfate
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 1004.463 167.4106 1865.609 17.63334
DC 6 1204.933 200.8221 1194.46 14.10946
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 3348.998 1 3348.998 2.188838 0.169812 4.964591
Within Groups 15300.34 10 1530.034
Total 18649.34 11
Table C40. Experiment 5: 24 hour proline incorporation ANOVA analysis.
Experiment 5 - 24 Hr Proline
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 819.8906 136.6484 985.9474 12.81891
DC 6 736.4277 122.7379 1926.988 17.92107
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 580.5046 1 580.5046 0.39857 0.541989 4.964591
Within Groups 14564.68 10 1456.468
Total 15145.18 11
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Table C41. Experiment 5: 24 hour GAG ANOVA analysis.
Experiment 5 - 24 Hr GAG
Anova: Single Factor
SUMMARY
Groups Count Sum Average Variance Std. Error
Control 6 810.0939 135.0157 441.0982 8.574168
DC 6 993.1862 165.531 327.9334 7.392941
ANOVA
Source of Variation SS df MS F P-value F crit
Between Groups 2793.567 1 2793.567 7.265154 0.02249 4.964591
ithin Groups 3845.158 10 384.5158
Total 6638.725 11
Experiment 6
Table C42. Experiment 6 cartilage harvest data.
Plug Thickness
Slice A B C D [mm]
1 Regular Regular - DC ITS ITS-DC 0.95
2 Regular Regular - DC ITS ITS-DC 0.95
3 Regular Regular - DC ITS ITS-DC 0.96
Regular Regular - DC ITS ITS-DC 0.98
5 Regular Regular - DC ITS ITS-DC 0.98
6 Regular Regular - DC ITS ITS-DC 0.98
7 Regular 2 Regular 2- DC A2P A2P-DC 0.99
8 Regular 2 Regular 2- DC A2P 2P-DC 1.02
9 Regular 2 Regular 2- DC A2P A2P-DC 1.02
10 Regular 2 Regular 2- DC A2P A2P-DC 1.03
11 Regular 2 Regular 2- DC A2P A2P-DC 0.97
12 Regular 2 Regular 2- DC A2P A2P-DC 0.98
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Table C43. Experiment 6 individual cartilage plug assay data.
Sample pmol Proline/ pmol Sulfate/ Normalized Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc. (ug DNA / hr) (ug DNA / hr) GAG Conc.
R_1 148.76 75.00 93.61 R_1 129.70 41.51 117.41
R_2 136.80 78.45 94.26 R_2 109.63 36.39 106.68
R_3 212.13 89.79 108.76 R_3 203.61 121.08 103.13
R_4 157.78 58.78 111.36 R_4 143.78 65.04 105.08
R_5 113.74 54.54 93.06 R_5 99.52 46.38 97.05
R 6 168.32 70.29 109.56 R 6 207.55 63.96 115.28
1_1 279.40 236.45 99.20 A_1 219.63 69.87 119.65
1_2 184.99 147.96 112.91 A_2 141.83 38.78 122.18
I_3 338.27 282.14 152.35 3 211.58 117.60 102.56
1_4 178.37 153.18 131.75 A4 132.99 56.37 109.67
1_5 175.83 148.46 117.83 A_5 199.97 144.75 85.12
1 6 174.01 138.39 118.54 6 138.39 30.14 108.36
R-DC_1 326.53 239.72 123.57 R-DC_1 235.84 129.23 156.59
R-DC_2 209.59 148.30 102.47 R-DC_2 248.46 160.24 153.05
R-DC_3 279.52 188.44 142.70 R-DC_3 182.81 129.14 136.63
R-DC_4 242.80 141.00 118.74R-DC_4 224.67 142.58 128.23
R-DC_5 162.20 117.93 101.21 R-DC_5 270.28 148.11 164.73
R-DC 6 218.83 140.72 116.06R-DC 6 217.19 129.61 161.04
I-DC_1 259.32 180.51 111.06 A-DC_1 217.11 128.90 138.12
I-DC_2 176.91 113.52 111.85A-DC_2 295.24 171.08 142.73
I-DC_3 247.34 178.92 118.95A-DC_3 165.87 106.15 122.69
I-DC_4 295.51 181.05 130.37 A-DC_4 247.81 147.76 152.18
I-DC_5 255.42 194.18 111.22 A-DC_5 135.33 105.86 123.52
-DC_6 273.90 196.01 110.42A-DC 6 192.41 128.29 134.74
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Table C44. Experiment 6 radiolabel protocol parameters.
Media Total 35S Activity 3H Activity Total "S Total 35S
Volume Concentration Concentration Volume Volume
[mL] [ptCi/ml_] [pCi/mL] [pL] [pL]
Regular 14.50 20.00 40.00 37.40 540.00
ITS 8.50 20.00 40.00 21.90 300.00
A2P 8.50 20.00 40.00 21.90 300.00
Table C45. Experiment 6, Regular vs. ITS Media: 2 hour sulfate incorporation ANOVA analysis.
xperiment 6 - Regular vs. ITS - Sulfate
nova: Two-Factor With Replication
TotalControl DCSUMMARY
Regular
Count 6 6 12
Sum 426.8442 976.1063 1402.95
Average 71.14069 162.6844 116.9125
Variance 169.008 1951.862 3249.554
ITS
Count 6 6 12
Sum 1106.566 1044.204 2150.771
Average 184.4277 174.034 179.2309
Variance 3594.587 933.1101 2087.506
Total
12
2020.311
168.3592
1346.483
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 23301.46 1 23301.46 1401894 0.001279 4.35125
Columns 9877.983 1 9877.983 _5942924 0.024235 4.35125
Interaction 15586.84 1 15586.84 9.377564 0.006148 4.35125
Within 33242.84 20 1662.142
Total 82009.13 23
Count
Sum
Average
Variance
12
1533.411
127.7842
5210.894
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Table C46. Experiment 6, Regular vs. ITS Media: 2 hour proline incorporation ANOVA analysis.
Experiment 6 - Regular vs. ITS - Proline
Anova: Two-Factor With Replication
TotalControl DCSUMMARY
Regular
Count 6 6 12
Sum 937.5419 1439.467 2377.009
verage 156.257 239.9111 198.0841
ariance 1102.491 3296.403 3908.048
ITS
Count 6 6 12
Sum 1330.867 1508.401 2839.268
verage 221.8111 251.4002 236.6057
Variance 4904.075 1619.218 3203.91
Total
12
2268.409
189.034
3902.261
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 8903.481 1 8903.481 3.260695 0.086034 4.35125
Columns 19236.04 1 19236.04 7.044759 0.015227 4.35125
Interaction 4384.551 1 4384.551 1.605741 0.219649 4.35125
Within 54610.93 20 2730.547
Total 87135.01 23
Count
Sum
Average
Variance
12
2947.868
245.6557
2270.373
108
Table C47. Experiment 6, Regular vs. ITS Media: 2 hour GAGANOVA analysis.
Experiment 6 - Regular vs. ITS -
GAG
Anova: Two-Factor With Replication
SUMMARY Control DC Total
Regular
Count 6 6 12
Sum 610.6075 704.7565 1315.364
Average 101.7679 117.4594 109.6137
Variance 80.10222 233.3252 209.6188
ITS
Count 6 6 12
Sum 732.5844 693.8517 1426.436
Average 122.0974 115.6419 118.8697
ariance 329.5284 62.01401 189.3391
Total
Count 12 12
Sum 1343.192 1398.608
verage 111.9327 116.5507
Variance 298.9106 135.146
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 514.0424 1 514.0424 2.916677 0.103145 4.35125
Columns 127.9569 1 127.9569 0.726028 0.404262 4.35125
Interaction 735.7313 1 735.7313 4.174541 0.054436 4.35125
Within 3524.849 20 176.2425
Total 4902.58 23
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Table C48. Experiment 6, Regular vs. A2P Media: 2 hour sulfate incorporation ANOVA analysis.
Experiment 6 - Regular vs. A2P - Sulfate
Anova: Two-Factor With Replication
SUMMARY Control DC Total
Regular
Count 6 6 12
Sum 374.3642 838.9093 1213.273
Average 62.39403 139.8182 101.1061
Variance 964.4741 164.8051 2148.173
A2P
Count 6 6 12
Sum 457.5063 788.0574 1245.564
Average 76.25105 131.3429 103.797
ariance 2073.657 629.5511 2056.489
Total
Count 12 12
Sum 831.8705 1626.967
verage 69.32254 135.5806
ariance 1433.337 380.6612
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 43.44425 1 43.44425 0.045343 0.83353 4.35125
Columns 26340.75 1 26340.75 27.49206 3.94E-05 4.35125
Interaction 748.0993 1 748.0993 0.780798 0.387396 4.35125
Within 19162.44 20 958.122
Total 46294.73 23
110
Table C49. Experiment 6, Regular vs. A2P Media: 2 hour proline incorporation ANOVA analysis.
Experiment 6 - Regular vs. A2P - Proline
Anova: Two-Factor With Replication
SUMMARY Control DC Total
Regular
Count 6 6 12
Sum 893.7886 1379.238 2273.027
Average 148.9648 229.873 189.4189
ariance 2161.744 883.3334 3169.439
A2P
Count 6 6 12
Sum 1044.388 1253.774 2298.162
verage 174.0646 208.9623 191.5135
Variance 1630.675 3314.428 2579.915
Total
Count 12 12
Sum 1938.176 2633.012
verage 161.5147 219.4177
Variance 1895.646 2027.325
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 26.32376 1 26.32376 0.013178 0.909752 4.3512.
Columns 20116.54 1 20116.54 10.07063 0.004777 4.3512,
Interaction 3175.455 1 3175.455 1.589679 0.221883 4.35125
Within 39950.9 20 1997.545
Total 63269.22 23
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Table C50. Experiment 6, Regular vs. A2P Media: 2 hour GAG ANOVA analysis.
Experiment 6 - Regular vs. A2P -
GAG
Anova: Two-Factor With Replication
Control DC TotalSUMMARY
Regular
Count 6 6 12
Sum 644.6433 900.2668 1544.91
Average 107.4406 150.0445 128.7425
Variance 58.6924 208.8719 616.6455
A2P
Count 6 6 12
Sum 647.5472 813.9828 1461.53
Average 107.9245 135.6638 121.7942
Variance 178.5044 129.0874 349.6693
Total
Count
Sum
Average
Variance
4NOVA
Source of Variation SS df MS F P-value F crit
Sample 289.6766 1 289.6766 2.014595 0.171192 4.35125
Columns 7422.247 1 7422.247 51.61901 5.89E-07 4.35125
Interaction 331.4359 1 331.4359 2.305015 0.144607 4.35125
Nithin 2875.781 20 143.789
Total 10919.14 23
12
1292.19
107.6825
107.8806
12
1714.25
142.8541
210.0187
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Experiment 7
Table C51. Experimen 7 cartilage harvest data.
Plug Thickness
Slice A B C D [mm]
1 Regular 1 Regular 1- DC ITS 1 ITS 1-DC 0.99
2 Regular 1 Regular 1- DC ITS 1 ITS 1-DC 1.00
3 Regular 1 Regular 1- DC ITS 1 ITS 1-DC 1.00
Regular 1 Regular 1- DC ITS 1 ITS 1-DC 0.99
5 Regular 1 Regular 1- DC ITS 1 ITS 1-DC 1.02
6 Regular 1 Regular 1- DC ITS 1 ITS 1-DC 1.02
7 Regular 2 Regular 2- DC ITS 2 ITS 2-DC 1.03
8 Regular 2 Regular 2- DC ITS 2 ITS 2-DC 1.03
9 Regular 2 Regular 2- DC ITS 2 ITS 2-DC 1.03
10 Regular 2 Regular 2- DC ITS 2 ITS 2-DC 1.04
11 Regular 2 Regular 2- DC ITS 2 ITS 2-DC 1.04
12 Regular 2 Regular 2- DC ITS 2 ITS 2-DC 1.05
Table C52. Experiment 7 individual cartilage plug assay data.
Sample pmol Proline/ pmol Sulfate/ Normalized Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc. (ug DNA / hr) (ug DNA / hr) GAG Conc.
R_1 267.45 131.32 Saturated R_1 291.65 123.41Saturated
R_2 209.59 89.48 Saturated R_2 175.52 92.44Saturated
R_3 179.34 66.80 Saturated R_3 216.32 130.13Saturated
R_4 131.85 59.97 Saturated R_4 194.95 107.49Saturated
R_5 184.40 75.25 Saturated R_5 164.00 83.36Saturated
R 6 194.19 116.57 Saturated R 6 220.66 98.13Saturated
I_1 357.39 182.63 Saturatedl_1 647.14 210.10Saturated
I_2 293.98 129.58 Saturatedl_2 305.15 151.45Saturated
I_3 357.05 186.65 Saturatedl_3 332.84 214.85Saturated
I_4 302.90 176.33 Saturatedl_4 316.72 232.21Saturated
I_5 530.19 231.55 Saturatedl_5 281.59 172.36Saturated
I 6 304.63 248.64 Saturatedl 6 426.38 316.08Saturated
R-DC_1 307.15 144.07 Saturated R-DC_1 392.86 196.59Saturated
R-DC_2 310.46 132.01 Saturated R-DC_2 289.59 151.83Saturated
R-DC_3 256.12 154.00 Saturated R-DC_3 250.57 122.73Saturated
R-DC_4 229.65 132.00 Saturated R-DC_4 237.40 167.28Saturated
R-DC_5 245.53 153.40 Saturated R-DC_5 244.75 154.85Saturated
R-DC 6 263.71 152.88 Saturated R-DC 6 291.51 155.33Saturated
I-DC_1 275.79 134.09 Saturatedl-DC_1 378.56 219.63Saturated
I-DC_2 270.56 118.24 Saturatedl-DC_2 247.65 161.77Saturated
I-DC_3 331.88 151.99 Saturatedl-DC_3 231.76 135.48Saturated
I-DC_4 300.12 154.61 Saturatedl-DC_4 212.34 121.60Saturated
I-DC_5 387.73 159.07 Saturatedl-DC_5 239.16 98.83Saturated
I-DC_ 6 95.24 12.62 Saturated I-DC 6 220.30 123.21 Saturated
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Table C53. Experiment 7 radiolabel protocol parameters.
Media Total 5sS Activity 3H Activity Total 35 S Total 31S
Volume Concentration Concentration Volume Volume
[mL] [pCi/mL] [pCi/mL] [pL[] [pL]
Regular 14.50 10.00 20.00 19.101 270.00
ITS 14.50 10.00 20.00 19.101 270.00
Table C54. Experiment 7, Trial 1: 2 hour sulfate incorporation ANOVA analysis.
Experiment 7 - Trial 1 - Sulfate
Anova: Two-Factor With Replication
SUMMARY Control DC Total
Regular
Count 5 5 10
Sum 422.821 715.4834 1138.304
verage 84.5642 143.0967 113.8304
Variance 804.3892 118.0405 1361.65
ITS
Count 5 5 10
Sum 906.7468 717.9942 1624.741
Average 181.3494 143.5988 162.4741
Variance 1313.637 291.1936 1109.12
Total
Count 10 10
Sum 1329.568 1433.478
verage 132.9568 143.3478
Variance 3543.391 181.9519
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 11831.02 1 11831.02 18.72546 0100052 4 4§998
Columns 539.8625 1 539.8625 0.854463 0.369025 4.493998
Interaction 11588.02 1 11588.02 18.34084 0.000571 4.493998
Within 10109.04 16 631.815
Total 34067.95 19
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Table C55. Experiment 7, Trial 1: 2 hour proline incorporation ANOVA analysis.
Experiment 7 - Trial 1 - Proline
Anova: Two-Factor With Replication
SUMMARY Control DC Total
Regular
Count 5 5 10
Sum 972.6248 1348.902 2321.527
Average 194.525 269.7803 232.1527
Variance 2451.463 1359.203 3266.788
ITS
Count 5 5 10
Sum 1841.511 1566.084 3407.595
Average 368.3022 313.2168 340.7595
Variance 9064.185 2322.966 5903.844
Total
Count 10 10
Sum 2814.136 2914.986
Average 281.4136 291.4986
Variance 13506.55 2160.611
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 58977.26 1 58977.26 15.52256 0.001171 4.493998
Columns 508.5358 1 508.5358 0.133844 0.719271 4.493998
Interaction 21235.88 1 21235.88 5.589193 0.031054 4.493998
Within 60791.27 16 3799.454
Total 141512.9 19
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Table C56. Experiment 7, Trial 2: 2 hour sulfate incorporation ANOVA analysis.
Experiment 7 - Trial 2 - Sulfate
Anova: Two-Factor With Replication
SUMMARY Control DC Total
Regular
Count 6 6 12
Sum 634.9547 948.6127 1583.567
verage 105.8258 158.1021 131.964
ariance 329.1727 574.8825 1156.247
ITS
Count 6 6 12
Sum 1297.043 860.5269 2157.57
Average 216.1739 143.4211 179.7975
Variance 3277.366 1816.267 3758.823
Total
Count 12 12
Sum 1931.998 1809.14
Average 160.9998 150.7616
ariance 4960.255 1145.667
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 13728.3 1 13728.3 9.155728 0.006676 4.35125
Columns 628.9254 1 628.9254 0.419445 0.524579 4.35125
Interaction 23448.4 1 23448.4 15.63829 0.000782 4.35125
Within 29988.44 20 1499.422
Total 67794.07 23
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Table C57. Experiment 7, Trial 2: 2 hour proline incorporation ANOVA analysis.
Experiment 7 - Trial 2 - Proline
Anova: Two-Factor With Replication
Control DC TotalSUMMARY
Regular
Count 6 6 12
Sum 1263.095 1706.689 2969.784
Average 210.5158 284.4482 247.482
Variance 2070.216 3353.168 3955.901
ITS
Count 6 6 12
Sum 2309.82 1529.771 3839.592
Average 384.9701 254.9619 319.966
Variance 18976.65 3827.435 14975.16
Total
Count
Sum
Average
Variance
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 31523.57 1 31523.57 4.467077 0.047316 4.35125
Columns 4716.739 1 4716.739 0.66839 0.423247 4.35125
Interaction 62387.63 1 62387.63 8.840697 0.007513 4.35125
Within 141137.4 20 7056.868
Total 239765.3 23
12
3572.915
297.7429
17867.02
12
3236.461
269.7051
3501.031
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Experiment 8
Table C58. Experiment 8 cartilage harvest data.
Plug Thickness
Slice A B C D [mm]
1 Regular 1 Regular 1- DC ITS-A2P 1 ITS-A2P 1-DC 0.99
2 Regular 1 Regular 1- DC ITS-A2P 1 ITS-A2P 1-DC 1.00
3 Regular 1 Regular 1- DC ITS-A2P 1 ITS-A2P 1-DC 1.00
4 Regular 1 Regular 1- DC ITS-A2P 1 ITS-A2P 1-DC 0.99
5 Regular 1 Regular 1- DC ITS-A2P 1 ITS-A2P 1-DC 1.02
6 Regular 1 Regular 1- DC ITS-A2P 1 ITS-A2P 1-DC 1.02
7 Regular 2 Regular 2- DC ITS-A2P 2 ITS-A2P 2-DC 1.03
8 Regular 2 Regular 2- DC ITS-A2P 2 ITS-A2P 2-DC 1.03
9 Regular 2 Regular 2- DC ITS-A2P 2 ITS-A2P 2-DC 1.03
10 Regular 2 Regular 2- DC ITS-A2P 2 ITS-A2P 2-DC 1.04
11 Regular 2 Regular 2- DC ITS-A2P 2 ITS-A2P 2-DC 1.04
12 Regular 2 Regular 2- DC ITS-A2P 2 ITS-A2P 2-DC 1.05
Table C59. Experiment 8 individual cartilage plug assa data.
Sample pmol Proline/ pmol Sulfate/ Normalized Sample pmol Proline/ pmol Sulfate/ Normalized
(ug DNA / hr) (ug DNA / hr) GAG Conc. (ug DNA / hr) (ug DNA / hr) GAG Conc.
R1_1 795.08 N/A 101.01 R2_1 353.57 N/A 135.22
R1_2 380.83 N/A 105.92 R2_2 444.95 N/A 133.23
R1_3 271.43 N/A 109.73 R2_3 677.13 N/A 85.30
R1_4 360.70 N/A 105.97 R2_4 376.35 N/A 176.64
R1_5 293.00 N/A 126.17 R2_5 931.16 N/A 384.86
R1 6 478.53 N/A 131.37 R2 6 495.14 N/A 172.04
R1-DC_1 25.72 N/A 113.54R2-DC_1 480.37 N/A 164.95
R1-DC_2 60.19 N/A 104.73 R2-DC_2 590.69 N/A 183.54
Ri-DC_3 125.11 N/A 161.26 R2-DC_3 429.20 N/A 121.92
Ri-DC_4 29.03 N/A 136.08 R2-DC_4 508.46 N/A 145.43
R1-DC_5 63.66 N/A 109.55 R2-DC_5 672.03 N/A 169.37
R1-DC 6 117.06 N/A 125.28 R2-DC 6 511.75 N/A 127.58
IA1_1 576.71 N/A 100.63A2_1 450.12 N/A 118.02
IA1_2 445.76 N/A 90.071A2_2 555.06 N/A 145.13
IA1_3 417.49 N/A 104.301A2_3 447.84 N/A 102.18
IAI_4 500.50 N/A 115.64A2_4 589.54 N/A 148.27
IA1_5 767.46 N/A 158.141A2_5 575.54 N/A 141.26
IA1 6 429.25 N/A 117.451A2 6 787.85 N/A 122.69
IAI-DC_1 20.39 N/A 109.451A2-DC_1 556.18 N/A 130.67
IAI-DC_2 80.72 N/A 108.721A2-DC_2 407.69 N/A 102.70
IA1-DC_3 57.85 N/A 130.081A2-DC_3 518.64 N/A 102.09
IA1-DC_4 109.23 N/A 110.121A2-DC_4 665.86 N/A 148.00
IA1-DC_5 57.14 N/A 121.731A2-DC_5 600.74 N/A 138.87
IA1-DC 6 118.94 N/A 117.941A2-DC 6 595.88 N/A 119.42
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Table C60. Experiment 8 radiolabel protocol parameters.
Media Total 35S Activity 3 H Activity Total 35 S Total 35S
Volume Concentration Concentration Volume Volume
[mL] [pCi/mL] [pCi/mL20 [pL] [p20
Regular 14.50 10.00 20.00 20.10 270.00
jITS-A2P 114.50 10.00 20.00 20.10 270.00
Table C61. Experiment 8, Trial 1: 2 hour sulfate incorporation ANOVA analysis.
Experiment 8 - Trial 1 - Sulfate
nova: Two-Factor With Replication
Regular
Count 6 6 12
Sum 2579.581 420.7755 3000.356
Average 429.9301 70.12926 250.0297
Variance 37354.79 1805.562 53106.53
IA
Count 6 6 12
Sum 3137.167 444.2589 3581.426
Average 522.8612 74.04315 298.4522
Variance 17807.58 1344.987 63643.25
Total
12
865.0344
72.0862
1436.245
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 14068.41 1 14068.41 0.965029 0.337658 4.35125
Columns 980796.8 1 980796.8 67.27818 7.91E--08 4.35125
Interaction 11886.08 1 11886.08 0.815331 0.377296 4.35125
Within 291564.6 20 14578.23
Total 1298316 23
Count
Sum
Average
Variance
12
5716.748
476.3957
27429.13
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SUMMARY Control DC Total
Table C62. Experiment 8, Trial 1: 2 hour GAG ANOVA analysis.
Experiment 8 - Trial 1 - GAG
nova: Two-Factor With Replication
Control DC TotalSUMMARY
Regular
Count 6 6 12
Sum 680.1749 750.4517 1430.627
verage 113.3625 125.0753 119.2189
Variance 152.8226 443.6511 308.5398
IA
Count 6 6 12
Sum 686.242 698.0288 1384.271
Average 114.3737 116.3381 115.3559
Variance 561.5761 72.93088 289.4647
Total
Count 12 12
1366.417
113.8681
325.0055
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 89.5357 1 89.5357 0.290941 0.595573 4.35125
Columns 280.6014 1 280.6014 0.911798 0.351038 4.35125
Interaction 142.5452 1 142.5452 0.463192 0.503939 4.35125
Within 6154.903 20 307.7452
Total 6667.585 23
Sum
Average
Variance
1448.48
120.7067
255.6294
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Table C63. Experiment 8, Trial 2: 2 hour sulfate incorporation ANOVA analysis.
Experiment 8 - Trial 2 - Sulfate
nova: Two-Factor With Replication
Control DC TotalSUMMARY
Regular
Count 6 6 12
Sum 3278.3 3192.508 6470.809
verage 546.3834 532.0847 539.2341
Variance 48831.15 7449.941 25638.07
IA
Count 6 6 12
Sum 3405.955 3344.994 6750.949
Average 567.6592 557.4989 562.5791
Variance 15470.44 7808.269 10609.39
Total
Count
Sum
Average
Variance
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 3269.941 1 3269.941 0.164402 0.689441 4.35125
Columns 897.3627 1 897.3627 0.045116 0.83394 4.35125
Interaction 25.68925 1 25.68925 0.001292 0.971688 4.35125
Within 397799 20 19889.95
Total 401992 23
12
6684.256
557.0213
29351.45
12
6537.502
544.7918
7111.7
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Table C64. Experiment 8, Trial 2: 2 hour GAG ANOVA analysis.
Experiment 8 - Trial 2 - GAG
Anova: Two-Factor With Replication
Control DC TotalSUMMARY
Regular
Count 6 6 12
Sum 1087.307 912.7801 2000.087
Average 181.2179 152.13 166.674
Variance 11039.01 601.6666 5521.972
IA
Count 6 6 12
Sum 777.552 741.76 1519.312
Average 129.592 123.6267 126.6093
Variance 331.9484 359.0681 323.8035
Total
12
1654.54
137.8783
658.2724
ANOVA
Source of Variation SS df MS F P-value F crit
Sample 9631.04 1 9631.04 3.123996 0.092403 4.35125
Columns 1843.09 1 1843.09 0.597838 0.448447 4.35125
Interaction 801.9773 1 801.9773 0.260135 0.61561 4.35125
Within 61658.46 20 3082.923
Total 73934.57 23
Count
Sum
Average
Variance
12
1864.859
155.4049
5895.499
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